Nothing Special   »   [go: up one dir, main page]

US6316158B1 - Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance - Google Patents

Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance Download PDF

Info

Publication number
US6316158B1
US6316158B1 US09/688,551 US68855100A US6316158B1 US 6316158 B1 US6316158 B1 US 6316158B1 US 68855100 A US68855100 A US 68855100A US 6316158 B1 US6316158 B1 US 6316158B1
Authority
US
United States
Prior art keywords
preform
temperature
cross
hours
uhmwpe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/688,551
Inventor
Kenneth Ashley Saum
William Michael Sanford
William Gerald Dimaio, Jr.
Edward George Howard, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Orthopaedics Inc
Original Assignee
DePuy Orthopaedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DePuy Orthopaedics Inc filed Critical DePuy Orthopaedics Inc
Priority to US09/688,551 priority Critical patent/US6316158B1/en
Priority to US10/056,684 priority patent/US6562540B2/en
Application granted granted Critical
Publication of US6316158B1 publication Critical patent/US6316158B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/048Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/14Plasma, i.e. ionised gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20Gaseous substances, e.g. vapours
    • A61L2/206Ethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • B29C35/0805Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
    • B29C2035/085Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation using gamma-ray
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/02Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor of articles of definite length, i.e. discrete articles
    • B29C43/16Forging
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/25Solid
    • B29K2105/253Preform
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/0087Wear resistance
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037Other properties
    • B29K2995/0089Impact strength or toughness
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/753Medical equipment; Accessories therefor
    • B29L2031/7532Artificial members, protheses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S522/00Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S522/911Specified treatment involving megarad or less
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S522/00Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S522/911Specified treatment involving megarad or less
    • Y10S522/912Polymer derived from ethylenic monomers only
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/92Method or apparatus for preparing or treating prosthetic

Definitions

  • This invention relates to a process for forming medical implants of cross-linked ultrahigh molecular weight polyethylene having an improved balance of wear properties and oxidation resistance.
  • ultrahigh molecular weight polyethylene can be cross-linked by irradiation with high energy radiation, for example gamma radiation, in an inert atmosphere or vacuum. Exposure of UHMWPE to gamma irradiation induces a number of free-radical reactions in the polymer. One of these is cross-linking. This cross-linking creates a 3-dimensional network in the polymer which renders it more resistant to adhesive wear in multiple directions. The free radicals formed upon irradiation of UHMWPE can also participate in oxidation which reduces the molecular weight of the polymer via chain scission, leading to degradation of physical properties, embrittlement and a significant increase in wear rate.
  • high energy radiation for example gamma radiation
  • the free radicals are very long-lived (greater than eight years), so that oxidation continues over a very long period of time resulting in as much as a 5-fold increase in the wear rate as a result of oxidation over a period of about 5 years.
  • the wear rate of traditionally irradiated materials is significantly greater than unirradiated materials.
  • a raw polymeric material is obtained by forming a virgin resin powder from which air and moisture have been removed prior to the forming process.
  • the forming process e.g. ram extrusion or compression molding of the powder is also preferably carried out in an inert low oxygen atmosphere.
  • a medical implant is formed from the raw material, e.g.
  • an olefinic material such as UHMWPE
  • UHMWPE an olefinic material
  • UHMWPE an olefinic material
  • the heating step forms cross-links between remaining free radicals formed during the radiation sterilization step, thus improving the oxidation resistance of the material.
  • the annealing temperature is too high, the thermal treatment can cause distortion of the UHMWPE implant, which is undesirable in orthopedic end-uses where the implants are generally machined or molded to close tolerances. If the temperature profile during annealing is adjusted to lower temperatures to avoid distortion of UHMWPE implants, incomplete extinguishing of the free radicals generally occurs and the UHMWPE oxidizes upon exposure to air or moisture.
  • the oriented UHMWPE materials have improved wear resistance. Medical implants may be machined from the oriented materials or molded directly during the compressive deformation step. The anisotropic nature of the oriented materials may render them susceptible to deformation after machining into implants.
  • Salovey et al. published European Application EP 722973 which application is hereby incorporated by reference, discloses a method for enhancing the wear-resistance of polymers, including UHMWTPE, by crosslinking them via irradiation in the melt or using peroxide or similar chemical agents.
  • the process of the present invention eliminates the problem of thermal distortion of the implant by irradiating and thermally treating a consolidated UHMWPE material prior to forming an implant therefrom.
  • the current invention allows one to use lower levels of irradiation for cross-linking than would be effective for sterilization of UHMWPE.
  • the heat treatment step following irradiation may be performed at temperatures near or above the melting point, which would distort the shape of a machined or molded implant which has been packaged for final sterilization.
  • An additional object of the current invention is to prepare a medical implant of cross-linked UHMWPE having improved wear properties without the use of chemical cross-linking agents.
  • Medical implants formed from the cross-linked UHMWPE material of the current invention may be packaged in an air-permeable package and sterilized using non-irradiative methods such as gas plasma or ethylene oxide, eliminating the need to package the implants in an inert atmosphere.
  • the cross-linked UHMWPE of the current invention can also be used in nonmedical applications requiring high wear resistance.
  • the current invention pertains to a process for preparing cross-linked ultrahigh molecular weight polyethylene useful in medical implants.
  • the process involves irradiating a preform of ultrahigh molecular weight polyethylene, preferably with gamma radiation.
  • the preform may be annealed prior to irradiation in an inert atmosphere without the application of external pressure.
  • the irradiated preform is then annealed in a substantially oxygen free atmosphere at a temperature at or above the onset of melting temperature, preferably near or above the peak DSC melting point, for a sufficient time to substantially recombine (eliminate) all the free radicals and crosslink the ultrahigh molecular weight polyethylene.
  • This annealing step may be done under isostatic or hydrostatic pressure.
  • the annealed preform is cooled while maintaining the oxygen free atmosphere and formed into a medical implant.
  • the implant is sterilized using non-irradiative methods. Sterilization preferably is done by packaging the implant in an air permeable package and treating with gas plasma.
  • the invention further pertains to an improved cross-linked ultrahigh molecular weight polyethylene that can be made by the process of this invention.
  • This cross-linked ultrahigh molecular weight polyethylene preferably has a swell ratio of less than about 5 and oxidation level of less than about 0.2 carbonyl area/mil sample thickness after aging under an oxygen pressure of about 5 atmospheres. It preferably has a percent elongation at break of at least 250, a single notch IZOD strength of at least 15 foot pounds per inch (ft lb/in) of notch, and a double notch IZOD strength of at least 35 ft lb/sq. in.
  • the medical implant of this cross-linked ultrahigh molecular weight polyethylene exhibits an improved balance of wear properties and oxidation resistance. Wear properties are superior to those of conventional ultrahigh molecular weight polyethylene sterilized using gas plasma or gamma-irradiation. Oxidative resistance is significantly improved over conventional gamma-sterilized ultrahigh molecular weight polyethylene and is comparable to unirradiated, gas plasma sterilized ultrahigh molecular weight polyethylene.
  • ultrahigh molecular weight polyethylene is defined as a polyethylene having an estimated weight average molecular weight in excess of about 400,000, usually 1,000,000 to 10,000,000 as defined by a melt index (ASTM D-1238) of essentially zero and a reduced specific viscosity greater than 8, preferably 25-30.
  • UHMWPE preform is used as the starting material in the current process.
  • the term preform is used herein to refer to a shaped article which has been consolidated, such as by ram extrusion or compression molding of UHMWPE resin particles into rods, sheets, blocks, slabs or the like.
  • Such preforms may be obtained or machined from commercially available UHMWPE, for example GUR 4150 HP ram extruded UHMWPE rods from PolyHi Solidur (Fort Wayne, Indiana).
  • the starting preform may also be pressure recrystallized as described in Howard U.S. Pat. No. 5,478,906, which patent is hereby incorporated by reference.
  • the UHMWPE preform material does not contain stabilizers, antioxidants, or other chemical additives which may have potential adverse effects in medical applications.
  • the process of the current invention includes the steps of irradiating a UHMWPE preform to form free radicals and cross-link the UHMWPE, annealing the irradiated UHMWPE preform at elevated temperature in a substantially oxygen free atmosphere to eliminate any free radicals remaining from the irradiation step, thus further cross-linking and increasing the oxidation resistance of the irradiated UHMWPE, and forming a medical implant from the annealed cross-linked preform.
  • Gamma radiation is preferably used in the irradiation step, however electron beam or x-ray radiation may also be used.
  • Ultrahigh molecular weight polyethylene prepared according to the process of the current invention has an improved balance of wear properties and oxidation resistance. The increased cross-linking results in reduced swell ratios, generally less than about 5, and improved wear performance with comparable oxidation resistance relative to unirradiated UHMWPE.
  • the preform is preferably irradiated in the solid state with gamma radiation at a dose of about 0.5-10 Mrad using methods known in the art.
  • the preform is irradiated at a dose of about 1.5-6 Mrad.
  • Radiation doses of less than about 0.5 Mrad generally provide insufficient cross-linking to provide the desired increase in wear properties in the final implant. While doses of greater than 10 Mrad may be used, generally the additional improvement in wear properties that is achieved by the higher dose is offset by increasing brittleness of the UHMWPE due to higher levels of cross-linking.
  • Ultrahigh molecular weight polyethylene prepared using the process of the current invention generally has a percent elongation at break of at least about 250, single notch Izod strength of at least about 15 ft lb/in of notch, preferably at least about 17 ft lb/in of notch, and double notch Izod strength of at least about 35 ft lb/sq in.
  • UHMWPE which has been pre-annealed or annealed at temperatures greater than about 280° C. generally have a percent elongation at break of at least about 400, preferably at least about 500.
  • the irradiation step is generally performed at room temperature, however higher temperatures may be used.
  • the preform is optionally contained in an inert atmosphere or vacuum, such as in an oxygen impermeable package during the irradiation step.
  • Inert gases such as nitrogen, argon, and helium may be used.
  • a vacuum the packaged material may be subjected to one or more cycles of flushing with an inert gas and applying a vacuum to eliminate oxygen from the package.
  • packaging materials include metal foil pouches such as aluminum or MYLAR® polyester coated packaging foil which is available commercially for heat-sealed vacuum packaging.
  • Polymeric packaging materials such as polyethylene terephthalate and poly(ethylene vinyl alcohol), both of which are commercially available may also be used.
  • Irradiating the preform in an inert atmosphere reduces the effect of oxidation and accompanying chain scission reactions which can occur during gamma-irradiation.
  • Oxidation that is caused by oxygen which is present in the atmosphere during irradiation is generally limited to the surface of the preform. Since the process of the current invention radiation cross-links the UHMWPE prior to forming the implant, low levels of surface oxidation can be tolerated as the oxidized surface can be removed during subsequent machining of the implant from the preform.
  • the UHMWPE preform After the UHMWPE preform has been gamma irradiated, it is heat treated by holding at elevated temperature in a substantially oxygen-free atmosphere, typically created by introducing inert gas or employing a vacuum, for a time that is sufficient to recombine substantially all of the free-radicals which remain in the material from the irradiation cross-linking step, thus further cross-linking the material and stabilizing it to oxidation.
  • Thermal distortion of the preform material during heat treatment may occur without affecting the final implant since the implant is formed from the preform after heat treatment. This allows higher temperatures to be used than would be possible in processes where the finished implants are heat treated.
  • the hold time required for reaction of the free radicals decreases with increasing temperature. Thus, a wide range of temperatures, including temperatures above the melting point of the UHMWPE, is acceptable in the heat treatment step of the current invention.
  • the irradiated preform preferably is heated at a temperature at or above the onset of melting temperature of the irradiated heat-treated preform material, and preferably at a temperature near or above the peak melting temperature of the irradiated heat-treated polymer for a time of 2-120 hours, preferably 5-60 hours, more preferably 12-60 hours.
  • the onset of melting temperature is defined herein as the temperature at the intersection of the baseline and steepest negative slope of the DSC melting endotherm.
  • the baseline intersects the initial portion of the melting endotherm and is tangent to the final portion of the curve.
  • the peak melting temperature is defined herein as the location of the peak of the melting endotherm.
  • the onset of melting temperature for irradiated, heat-treated UHMWPE is generally about 120° C. and the peak melting temperature is generally between 135° C. and 140° C.
  • An especially preferred embodiment of the current invention is irradiation with a dose of 1.5-6 Mrads followed by heat treatment at 150-170° C. for a period of 6-60 hours, more preferably 12-60 hours.
  • the temperature and hold time that is sufficient to react substantially all of the free-radicals may be determined by measuring the oxidation of the samples using the method described below.
  • the temperature and hold time are chosen such that oxidation levels of less than about 0.2 carbonyl area/mil sample thickness, preferably less than about 0.1 carbonyl area/mil sample thickness, after aging as measured by this method are obtained.
  • Heat treatment at or above the onset of melting temperature results in improved molecular mobility and elimination of free radicals in the crystalline regions of the polymer and increased cross-linking and reduced oxidation in aged samples.
  • heat treatment is carried out at lower temperatures, elimination of free radicals is less complete resulting in higher levels of residual oxidation upon aging.
  • Standard UHMWPE may be irradiated and pressure recrystallized to convert the UHMWPE into an extended chain conformation by conducting the heat treatment step using the temperatures and pressures disclosed for pressure recrystallization in U.S. Pat. No. 5,478,906.
  • pressure recrystallizing UHMWPE the polymer is placed in a pressure vessel in water and enough pressure to withstand the pressure the water will develop at the operating temperatures. The temperature of the vessel is raised to melt the polyethylene which generally melts at 135-150° C. at one atmosphere, and about 200° C. at 50,000 psi. The time required to melt the polymer depends on the size of the UHMWPE preform used.
  • UHMWPE is a poor heat conductor and has a very high heat of crystallization, it can take 1-2 hours to heat a 3 in. diameter rod to 200° C. with the vessel at 220° C. Once the polymer is hot and molten, the pressure is applied. Preferred pressures are about 33 kpsi (230 MPa) to 70 kpsi (480 MPa). Further improvement in properties may be achieved by annealing the UHMWPE in an inert atmosphere at temperatures above the melting point prior to pressure recrystallization. Pressures of greater than 45 kpsi (310 MPa) are preferred for pressure recrystallization of material which is pre-annealed prior to pressure recrystallization.
  • the cooling time normally is about 6 hours from 250° C. to 75° C., but forced cooling of the vessel can reduce this to 1-2 hours with no adverse effects on the product.
  • the UHMWPE material prepared according to the process of the current invention is an isotropic material, with no significant molecular or crystalline orientation.
  • thermal treatment after irradiation is preferably performed in such a manner that no non-uniform forces which could lead to deformation of the material during heat treatment will occur.
  • the preform can be subjected to uniform pressure, such as isostatic or hydrostatic pressure, or alternatively, the preform can be heated in the absence of any externally applied pressure, so as to not deform the UHMWPE. It is undesirable to deform the preform by application of compressive or other forces as this results in an oriented material which may deform due to internal stresses after machining of the implant.
  • the cross-linked preform is cooled while still in an inert atmosphere or vacuum.
  • the cross-linked preform is cooled to a temperature less than about 100° C., preferably less than about 50° C., more preferably to room temperature, prior to exposing the preform to air.
  • the preform was packaged during the heat treatment step, after cooling it is removed from the packaging and formed into an implant using methods known in the art such as machining.
  • the cross-linked UHMWPE is especially useful as a bearing surface, for example in prosthetic hip joint cups and as other prosthetic shapes for replacement of other joints of the human body, including knees, shoulders, fingers, spine, and elbows.
  • the finished implant is then packaged and sterilized using non-radical-forming methods.
  • the implant is oxidatively stabilized, it is not necessary to package the finished implant in an inert atmosphere.
  • the implant can be packaged in air-permeable packaging and sterilized using gas plasma or ethylene oxide methods which are known in the art.
  • gas plasma or ethylene oxide methods which are known in the art.
  • a PLAZLYTE® gas plasma sterilization unit manufactured by Abtox (Mundelein, Ill.), may be used.
  • the UHMWPE preform is pre-annealed prior to the irradiation step.
  • the preform is subjected to a temperature of 280° C.-355° C., preferably 320° C.-355° C., for at least 0.5 hour, preferably at least 3 hours, in an inert atmosphere, without the application of external pressure. It is generally desirable to heat the polymer as close as possible to, without reaching, its decomposition temperature.
  • the pre-annealed preform is then cooled non-precipitously to a temperature of about 130° C. or below, the rate of cooling being such that temperature gradients producing internal stresses in the article are substantially avoided.
  • Rapid cooling such as by immersion in cold water, should be avoided as it causes internal voids to form. It is generally convenient to allow the polymer to cool wrapped in insulation.
  • the pre-annealed preform has improved elongation, impact resistance, and crystallinity over the starting UHMWPE.
  • the cooled pre-annealed preform is then irradiated and annealed as described above.
  • test specimens were prepared from the interior of the preform rods.
  • Type IV tensile specimens comforming to ASTM D-638 were machined from the UHMWPE sample materials. The test specimens were mounted in a Lloyd LR10K mechanical test frame and tested for the tensile yield stress (TYS), ultimate tensile stress (UTS) and percent elongation according to ASTM D-638. Type IV specimens were used to measure UTS, TYS, and percent elongation for Examples 1-27, and Comparative Examples A-C.
  • Type I tensile specimens were machined from the UHMWPE samples and mounted in the test frame. Tensile modulus was measured on these samples according to ASTM D-638. Type I tensile specimens were also used to measure TYS, UTS and percent elongation for Examples 28-37 and Comparative Example D.
  • Thermal analysis was performed on disks approximately 3 mm thick and 1.5 mm in diameter which were cut from the UHMWPE sample rod.
  • the disk was placed in a differential scanning calorimetry (DSC) sample pan and weighed. The lid was placed on the pan and crimped in place.
  • the pan was placed in a DuPont Model 2000 thermal analyzer and allowed to equilibrate at a temperature of 50° C. It was then heated at a rate of 20 degrees C./minute.
  • the peak melting point was taken as the location of the peak of the melting endotherm.
  • the onset of melting temperature was determined from the DSC curve as the intersection of the baseline and the steepest negative slope of the melting endotherm.
  • the baseline intersects the initial portion of the melting endotherm and is tangent to the final portion of the curve.
  • the heat of fusion (Hf) was calculated as the area of the melting endotherm.
  • the percent crystallinity was determined by dividing the measured heat of fusion by the theoretical heat of fusion of crystalline UHMWPE, 290 J/g.
  • Density measurements were performed on 1.5 mm thick disks of UHMWPE cut from the UHMWPE sample rods. The disks were soaked in a 65/35 solution by weight of 2-propanol, histological grade, and water. The sample was placed into a calibrated density gradient column. The density was determined from the equilibrium position of the sample in the column and is reported as g/cc.
  • Impact resistance was measured using the notched Izod test given in ASTM D-256 with the following modifications: samples machined into shape without the use of lubricating liquid; type A or notched IZOD; specimen size was 0.5 in. ⁇ 2.5 in.; 0.4 in. from bottom of vertex to opposite side; 1.25 in. impacted end (from end of bar to vertex of notch); the notch should be the specified angle of 22.5 degrees. Impact strength was also measured using double notched Izod specimens and the test method described in ASTM F-648 Annex A1.
  • Oxidative aging was performed on specimens which were wrapped in porous breather fabric to prevent close packing of the specimens and allow free gas access to all surfaces. The specimens were then loaded into a 4 in. ⁇ 8 in. cylindrical pressure bomb and sealed. The bomb was pressurized to 5 atmospheres (73.5 psi) with oxygen and heated with cylindrical band heaters to 70° C. and held for 14 days. Aged wear test results were obtained by aging the hip cups using this procedure prior to wear testing. Similarly, aged Izod specimens for double notch impact strength measurements were prepared according to ASTMF-648 Annex A1 followed by oxidative aging prior to strength measurements.
  • Specimens for oxidation measurements were cut from the interior of the cooled preform rods after gamma-irradiation and annealing. The samples were 45 degree wedge cuts from 0.5 inch thick by 2.5 inch diameter disks. Oxidation measurements were made on 250 micron thick sections prepared by cutting the wedge-shaped specimens through their thickness using a band saw. A 250 micron thick slice was microtomed off the freshly exposed surface and analyzed using FTIR. Aged oxidation results were obtained from wedge cuts that were aged according to the oxidative aging procedure described above prior to preparing the 250 micron thick section. The sample was mounted in a Digilab FTIR fitted with a microscope with a motorized stage.
  • the FTIR aperture was focused through the microscope to allow measurement of the infrared absorbance in a small (25 micron ⁇ 200 micron) section of the sample.
  • the microscope stage was moved by a stepper motor in increments of 50 microns to measure the carbonyl absorbance at a number of locations from the surface down to a depth of 4 mm.
  • Oxidation was quantified based on the absorbance of the carbonyl peaks at 1670-1730 wavenumbers as compared to a reference peak corresponding to methylene stretching along the polymer backbone at 4250 wavenumber using the method of Nagy & Li, A Fourier Transform Infrared Technique For The Evaluation of Polyethylene Bearing Materials, Transactions, 16th Annual Meeting, The Society for Biomaterials, 3:109, 1990.
  • An average oxidation level was calculated by integrating the carbonyl concentration versus depth curve to a depth of 2.05 mm. Oxidation is reported as carbonyl area/mil sample thickness.
  • Swell ratios were measured per ASTM D 2765 method C. The test specimens were 0.32 inch cubes. All swell ratios represent the average of 4 test specimens.
  • Gas plasma sterilization was performed by (a) placing the component in a breathable pouch and heat sealing, (b) placing the packaged components in the chamber of a PLAZLYTE® Sterilization System (Abtox, Inc., Mundelein, Ill.) and evacuating (c) filling the chamber with peracetic acid vapor and holding for a predetermined time, (d) evacuting the chamber, (e) filling the chamber with a filtered secondary plasma and holding for a predetermined time, (f) evacuating the chamber, (g) repeating steps (c)-(f), (h) filling the chamber with atmospheric air, (i) evacuating the chamber, and (3) repeating steps (h) and (i) to complete the cycle.
  • a PLAZLYTE® Sterilization System Abtox, Inc., Mundelein, Ill.
  • Wear rates were obtained by mounting test hip cups having a 28 mm spherical hole in the cup in a hip simulating wear tester which included 28 mm diameter femoral heads.
  • the test cups were machined from the interior of the preform rods and were pre-soaked for 30 days in bovine calf serum solution containing 20 mM EDTA and 0.2 wt % sodium azide.
  • the cups were sterilized by gas plasma prior to wear testing.
  • the wear tester simulated the human gait using the Paul hip curve at a 1900 N peak load and a frequency of 1.1 Hz. The load is applied in the vertical direction.
  • the test cup in the hip simulator is immersed in bovine calf serum and angled at 23 degrees from the horizontal. Every 500,000 cycles, the cups are washed, dried and weighed. Each test was run between 2.5 and 5 million cycles. Soak controls cups were used to correct for fluid absorption.
  • the wear rate is the soak corrected change in cup weight per million cycles.
  • the UHMWPE preform comprised GUR 4150 HP ram-extruded UHMWPE (PolyHi Solidur, Fort Wayne, Ind.) in the form of 3.5 in. (8.9 cm) diameter rods approximately 30 in. (76.2 cm) in length.
  • This polymer has a molecular weight of approximately 6 million, a peak melting point of about 135° C., and a percentage crystallinity of about 45-55%.
  • Rods of UHMWPE as described above were placed in separate pouches of heat sealable packaging foil having a MYLAR® polyester coating, SP Class E style 1.40 sleevestock (Shield Pack, Inc., West Monroe, La.), flushed with nitrogen and then evacuated. This procedure was repeated and the pouches were then sealed under vacuum.
  • the rod of Example 1 was irradiated with a dose of 1 Mrad of gamma irradiation from a Cobalt-60 source. Gamma irradiation was performed by Isomedix (Morton Grove, Ill.).
  • the rods of Examples 2 and 3 were irradiated with doses of 2.5 Mrads and 5 Mrads, respectively.
  • Example 3 After irradiation, the packaged rods were placed individually in an oven at a temperature of 325° C. and held at that temperature for 4.5 hours. At the end of 4.5 hours, the rods were cooled in the oven at about 20° C./hr to ambient temperature in their packages. The cooled rods were then removed from their packages and mechanical and physical properties and oxidation were measured as described above. The results and process conditions are shown in Table I. These examples show excellent oxidation resistance under both aged and unaged conditions compared to Comparative Examples A, B, and C. The effect is greatest for Example 3 (vs. Comparative Example C) which was irradiated at the higher dose of 5 Mrads. Aged and unaged oxidation resistance for Examples 1-3 is comparable to unirradiated Example D.
  • UHMWPE rods for comparative Examples A and C were packaged under vacuum as described in Examples 1-3, and irradiated at doses of 1 Mrad and 5.0 Mrad, respectively.
  • the rod of Comparative Example B was irradiated with 2.5 Mrad in air without packaging.
  • the rods were not heat-treated after irradiation.
  • Mechanical and physical properties and oxidation were measured as described above. The results and process conditions are shown in Table I. Test specimens were taken from the interior of the rod, thus substantially eliminating any effects of oxidation in comparative Example B which was irradiated in air.
  • Example B an unaged wear rate of 15 mg/million cycles and an aged wear rate of 88 mg/million cycles were measured after 5 million cycles.
  • Example B shows the effect of this oxidation on impact strength and wear. Impact strength is reduced by a factor of 10 after aging. Although the unaged wear rate for Example B is improved compared to Comparative Example D, the wear rate is increased by nearly 6 ⁇ after aging, significantly higher than the wear rate for Comparative Example D.
  • the UHMWPE rods for this example were not irradiated, heat treated or pressurized. They were gas plasma sterilized by a PLAZLYTE® Sterilization System (Abtox Inc., Mundelein, Ill.). The mechanical and physical properties are similar to commercially available UHMWPE rods and are shown in Table V. An unaged wear rate of 30 mg/million cycles and an aged wear rate of 33 mg/million cycles were obtained after 5 million cycles.
  • Hoechst GUR 415 UHMWPE in the form of 3 in. (7.6 cm) diameter rods obtained from PolyHi Solidur were cut to about 15 in. (38.1 cm) length and sealed in polyethylene lined aluminum foil bags under a nitrogen atmosphere.
  • the rods were irradiated with Co-60 gamma rays and aged for one month in the sealed bags to permit the free radicals to react. Irradiation doses of 0.5, 1, 2, and 5 Mrad were used.
  • the bars were then removed from the bags and immediately placed in a pressure vessel, as described in Simmons et al. U.S. Pat. No. 5,236,669, which patent is hereby incorporated by reference.
  • Pressure recrystallization was conducted by sealing the vessel and pressurizing with water to about 5000 psi. The vessel was then heated over a period of 1.5 hours to 250° C. After 2 hours, the pressure was raised to 50,000 psi and maintained there for the rest of the pressure treatment.
  • the 3 in. diameter GUR 415 UHMWPE rods were pre-annealed at 325° C. for 4.5 hours in nitrogen, cooled in nitrogen at approximately 20° C./hr, and then sealed in aluminum foil/polyethylene bags under nitrogen. The bars were then irradiated with gamma rays. After aging one month, the polymers were pressure recrystallized as described above. Process conditions and results are given in Table III. The polymer was converted to extended chain form only at higher pressure. The samples treated with 50,000 psi during pressure recrystallization had higher melting points, higher heats of fusion, higher tensile moduli, higher maximum strengths, higher tensile strength at yield, higher Izod impact strength, and improved creep resistance.
  • the pre-annealed samples of Examples 16-21 have higher elongations than the corresponding samples of Examples 4, 5, 7, 8, 10 and 11 which were not pre-annealed.
  • Examples 22-23 and 24-25 show excellent oxidation resistance in both the aged and unaged states as did Examples 1-3, also due to substantially complete quenching of free radicals during the pressure recrystallization step.
  • the samples also show increased crystallinity, which in turn shows that it is possible to change the crystal structure of the polymer even in the presence of crosslinks.
  • UHMWPE rods 28-30 were packaged and processed as described in Example 2 (2.5 Mrad) except that the rods were heated at 155° C. for 6, 24, and 48 hours respectively, removed from the oven and cooled.
  • the process conditions, mechanical and physical properties are shown in Table V. These examples show that annealing at 155° C. creates a material with excellent oxidation resistance. Irradiated samples 28-30 exhibited a reduction in double notched Izod compared to the unirradiated Comparative Example D. It also shows that the crosslinking produced by the 2.5 Mrad radiation dose yields a swell ratio of 3.9 as compared to 24.1 for Example D. An unaged wear rate of 14 mg/million cycles was measured after 5 million cycles for hip cups prepared from the cross-linked polymer of Example 30.
  • UHMWPE rods 31, 32 and 33 were packaged and processed as described in Example 3 (5 Mrad) except that the rods were heated to 155° C. for 6, 24 and 48 hours respectively, removed from the oven, and cooled.
  • the process conditions, mechanical and physical properties are shown in Table V. These examples show that UHMWPE exposed to 5 Mrads of gamma irradition then annealed at 155° C. also gives excellent oxidation resistance. It also shows that the radiation dose reduces the impact strength and the elongation. A comparison of these swell ratios, 2.6, with Examples 28-30 and D, show that crosslinking is increased with radiation dose.
  • Example 32 An unaged wear rate of 0.8 mg/million cycle and an aged wear rate of 0.6 mg/million cycles were measured for Example 32 after 2.5 million cycles.
  • the wear rate of Example 32 is greatly reduced compared to Examples 30, B and D.
  • the wear and oxidation resistance of this material is greatly improved over material that is irradiated but not annealed. Oxidation resistance is comparable to unirradiated polymer (Comparative Example D) and wear performance is significantly improved.
  • UHMWPE rods 34, 35 and 36 were packaged and processed as described in Example 3 (5 Mrad) except that the rods were heated to 200° C. for 6, 24 and 48 hours respectively, removed from the oven and cooled.
  • the process conditions, mechanical and physical properties are shown in Table V. These examples show that annealing at 200° C. is also effective for producing an oxidation resistant material.
  • This rod was packaged and processed as described in Example 3 (5 Mrad) except the rod was heated to 120° C. for 48 hours, removed from the oven, and cooled. An unaged wear rate of 5 mg/million cycles was measured after 5 million cycles. Results are shown in Table V. This example shows the improved wear resistance of a material crosslinked at 5 Mrads and annealed at 120° C. for 48 hours as compared to Examples 30 (2.5 Mrad, 155° C./48 hrs), C (5 Mrad, unannealed), and D (unirradiated).

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Plasma & Fusion (AREA)
  • Materials For Medical Uses (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Prostheses (AREA)

Abstract

A medical implant of ultrahigh molecular weight polyethylene having an improved balance of wear properties and oxidation resistance is prepared by irradiating a preform of ultrahigh molecular weight polyethylene, annealing the irradiated preform in the absence of oxygen to a temperature at or above the onset of melting temperature, and forming an implant from the stabilized cross-linked polymer. Implants prepared according to the process of the present invention have comparable oxidation resistance and superior wear performance compared to unirradiated ultrahigh molecular weight polyethylene.

Description

CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation of U.S. application Ser. No. 09/422,722, filed Oct. 22, 1999, now allowed, which is a continuation of U.S. application Ser. No. 08/911,792, filed Aug. 15, 1997, now U.S. Pat. No. 6,017,975, issued on Jan. 25, 2000, which claims priority to U.S. application Ser. No. 60/027,354, filed Oct. 2, 1996, now abandoned, the specifications of which are herein incorporated by reference.
BACKGROUND OF INVENTION
1. Field of Invention
This invention relates to a process for forming medical implants of cross-linked ultrahigh molecular weight polyethylene having an improved balance of wear properties and oxidation resistance.
2. Description of Related Art
It is known in the art that ultrahigh molecular weight polyethylene (UHMWPE) can be cross-linked by irradiation with high energy radiation, for example gamma radiation, in an inert atmosphere or vacuum. Exposure of UHMWPE to gamma irradiation induces a number of free-radical reactions in the polymer. One of these is cross-linking. This cross-linking creates a 3-dimensional network in the polymer which renders it more resistant to adhesive wear in multiple directions. The free radicals formed upon irradiation of UHMWPE can also participate in oxidation which reduces the molecular weight of the polymer via chain scission, leading to degradation of physical properties, embrittlement and a significant increase in wear rate. The free radicals are very long-lived (greater than eight years), so that oxidation continues over a very long period of time resulting in as much as a 5-fold increase in the wear rate as a result of oxidation over a period of about 5 years. As such, the wear rate of traditionally irradiated materials is significantly greater than unirradiated materials.
Sun et al. U.S. Pat. No. 5,414,049, which patent is hereby incorporated by reference, discloses a process for improving the oxidation resistance of medical implants which have been sterilized with radiation. In a preferred embodiment, a raw polymeric material is obtained by forming a virgin resin powder from which air and moisture have been removed prior to the forming process. The forming process, e.g. ram extrusion or compression molding of the powder is also preferably carried out in an inert low oxygen atmosphere. A medical implant is formed from the raw material, e.g. an olefinic material such as UHMWPE, and is sealed in an oxygen impermeable package in an oxygen reduced non-reactive atmosphere and radiation sterilized, followed by heating the sterilized packaged implant at a temperature of between 37° C. and the melting point of the olefinic material. The heating step forms cross-links between remaining free radicals formed during the radiation sterilization step, thus improving the oxidation resistance of the material. If the annealing temperature is too high, the thermal treatment can cause distortion of the UHMWPE implant, which is undesirable in orthopedic end-uses where the implants are generally machined or molded to close tolerances. If the temperature profile during annealing is adjusted to lower temperatures to avoid distortion of UHMWPE implants, incomplete extinguishing of the free radicals generally occurs and the UHMWPE oxidizes upon exposure to air or moisture.
Hyun et al. published International Application WO 96/09330, which application is hereby incorporated by reference, discloses a process for forming oriented UHMWPE materials for use in artificial joints by irradiating with low doses of high-energy radiation in an inert gas or vacuum to cross-link the material to a low degree, heating the irradiated material to a temperature at which compressive deformation is possible, preferably to a temperature near the melting point or higher, and performing compressive deformation followed by cooling and solidifying the material. The oriented UHMWPE materials have improved wear resistance. Medical implants may be machined from the oriented materials or molded directly during the compressive deformation step. The anisotropic nature of the oriented materials may render them susceptible to deformation after machining into implants.
Salovey et al. published European Application EP 722973, which application is hereby incorporated by reference, discloses a method for enhancing the wear-resistance of polymers, including UHMWTPE, by crosslinking them via irradiation in the melt or using peroxide or similar chemical agents.
The process of the present invention eliminates the problem of thermal distortion of the implant by irradiating and thermally treating a consolidated UHMWPE material prior to forming an implant therefrom. By separating the irradiation cross-linking step from the sterilization step, the current invention allows one to use lower levels of irradiation for cross-linking than would be effective for sterilization of UHMWPE. Additionally, the heat treatment step following irradiation may be performed at temperatures near or above the melting point, which would distort the shape of a machined or molded implant which has been packaged for final sterilization. Heat treatment near or above the melting point results in improved molecular mobility, elimination of free radicals in the crystalline regions of the polymer which cannot occur at temperatures below the melt, and increased cross-linking and reduced oxidation in aged samples. When heat treatment is carried out at lower temperatures, incomplete quenching of free radicals results in residual oxidation upon aging., By separating the irradiating and annealing steps, the process of the current invention also avoids the need to irradiate in the melt, which is difficult to achieve on a commercial scale. An additional object of the current invention is to prepare a medical implant of cross-linked UHMWPE having improved wear properties without the use of chemical cross-linking agents. Medical implants formed from the cross-linked UHMWPE material of the current invention may be packaged in an air-permeable package and sterilized using non-irradiative methods such as gas plasma or ethylene oxide, eliminating the need to package the implants in an inert atmosphere. The cross-linked UHMWPE of the current invention can also be used in nonmedical applications requiring high wear resistance.
SUMMARY OF THE INVENTION
The current invention pertains to a process for preparing cross-linked ultrahigh molecular weight polyethylene useful in medical implants. The process involves irradiating a preform of ultrahigh molecular weight polyethylene, preferably with gamma radiation. Optionally, the preform may be annealed prior to irradiation in an inert atmosphere without the application of external pressure. The irradiated preform is then annealed in a substantially oxygen free atmosphere at a temperature at or above the onset of melting temperature, preferably near or above the peak DSC melting point, for a sufficient time to substantially recombine (eliminate) all the free radicals and crosslink the ultrahigh molecular weight polyethylene. This annealing step may be done under isostatic or hydrostatic pressure. The annealed preform is cooled while maintaining the oxygen free atmosphere and formed into a medical implant. The implant is sterilized using non-irradiative methods. Sterilization preferably is done by packaging the implant in an air permeable package and treating with gas plasma.
The invention further pertains to an improved cross-linked ultrahigh molecular weight polyethylene that can be made by the process of this invention. This cross-linked ultrahigh molecular weight polyethylene preferably has a swell ratio of less than about 5 and oxidation level of less than about 0.2 carbonyl area/mil sample thickness after aging under an oxygen pressure of about 5 atmospheres. It preferably has a percent elongation at break of at least 250, a single notch IZOD strength of at least 15 foot pounds per inch (ft lb/in) of notch, and a double notch IZOD strength of at least 35 ft lb/sq. in. The medical implant of this cross-linked ultrahigh molecular weight polyethylene exhibits an improved balance of wear properties and oxidation resistance. Wear properties are superior to those of conventional ultrahigh molecular weight polyethylene sterilized using gas plasma or gamma-irradiation. Oxidative resistance is significantly improved over conventional gamma-sterilized ultrahigh molecular weight polyethylene and is comparable to unirradiated, gas plasma sterilized ultrahigh molecular weight polyethylene.
DETAILED DESCRIPTION
For the purposes of this invention ultrahigh molecular weight polyethylene is defined as a polyethylene having an estimated weight average molecular weight in excess of about 400,000, usually 1,000,000 to 10,000,000 as defined by a melt index (ASTM D-1238) of essentially zero and a reduced specific viscosity greater than 8, preferably 25-30.
An UHMWPE preform is used as the starting material in the current process. The term preform is used herein to refer to a shaped article which has been consolidated, such as by ram extrusion or compression molding of UHMWPE resin particles into rods, sheets, blocks, slabs or the like. Such preforms may be obtained or machined from commercially available UHMWPE, for example GUR 4150 HP ram extruded UHMWPE rods from PolyHi Solidur (Fort Wayne, Indiana). The starting preform may also be pressure recrystallized as described in Howard U.S. Pat. No. 5,478,906, which patent is hereby incorporated by reference. The UHMWPE preform material does not contain stabilizers, antioxidants, or other chemical additives which may have potential adverse effects in medical applications.
The process of the current invention includes the steps of irradiating a UHMWPE preform to form free radicals and cross-link the UHMWPE, annealing the irradiated UHMWPE preform at elevated temperature in a substantially oxygen free atmosphere to eliminate any free radicals remaining from the irradiation step, thus further cross-linking and increasing the oxidation resistance of the irradiated UHMWPE, and forming a medical implant from the annealed cross-linked preform. Gamma radiation is preferably used in the irradiation step, however electron beam or x-ray radiation may also be used. Ultrahigh molecular weight polyethylene prepared according to the process of the current invention has an improved balance of wear properties and oxidation resistance. The increased cross-linking results in reduced swell ratios, generally less than about 5, and improved wear performance with comparable oxidation resistance relative to unirradiated UHMWPE.
The preform is preferably irradiated in the solid state with gamma radiation at a dose of about 0.5-10 Mrad using methods known in the art. Preferably, the preform is irradiated at a dose of about 1.5-6 Mrad. Radiation doses of less than about 0.5 Mrad generally provide insufficient cross-linking to provide the desired increase in wear properties in the final implant. While doses of greater than 10 Mrad may be used, generally the additional improvement in wear properties that is achieved by the higher dose is offset by increasing brittleness of the UHMWPE due to higher levels of cross-linking. Ultrahigh molecular weight polyethylene prepared using the process of the current invention generally has a percent elongation at break of at least about 250, single notch Izod strength of at least about 15 ft lb/in of notch, preferably at least about 17 ft lb/in of notch, and double notch Izod strength of at least about 35 ft lb/sq in. UHMWPE which has been pre-annealed or annealed at temperatures greater than about 280° C. generally have a percent elongation at break of at least about 400, preferably at least about 500. The irradiation step is generally performed at room temperature, however higher temperatures may be used.
The preform is optionally contained in an inert atmosphere or vacuum, such as in an oxygen impermeable package during the irradiation step. Inert gases such as nitrogen, argon, and helium may be used. If a vacuum is used, the packaged material may be subjected to one or more cycles of flushing with an inert gas and applying a vacuum to eliminate oxygen from the package. Examples of packaging materials include metal foil pouches such as aluminum or MYLAR® polyester coated packaging foil which is available commercially for heat-sealed vacuum packaging. Polymeric packaging materials such as polyethylene terephthalate and poly(ethylene vinyl alcohol), both of which are commercially available may also be used. Irradiating the preform in an inert atmosphere reduces the effect of oxidation and accompanying chain scission reactions which can occur during gamma-irradiation. Oxidation that is caused by oxygen which is present in the atmosphere during irradiation is generally limited to the surface of the preform. Since the process of the current invention radiation cross-links the UHMWPE prior to forming the implant, low levels of surface oxidation can be tolerated as the oxidized surface can be removed during subsequent machining of the implant from the preform.
After the UHMWPE preform has been gamma irradiated, it is heat treated by holding at elevated temperature in a substantially oxygen-free atmosphere, typically created by introducing inert gas or employing a vacuum, for a time that is sufficient to recombine substantially all of the free-radicals which remain in the material from the irradiation cross-linking step, thus further cross-linking the material and stabilizing it to oxidation. Thermal distortion of the preform material during heat treatment may occur without affecting the final implant since the implant is formed from the preform after heat treatment. This allows higher temperatures to be used than would be possible in processes where the finished implants are heat treated. The hold time required for reaction of the free radicals decreases with increasing temperature. Thus, a wide range of temperatures, including temperatures above the melting point of the UHMWPE, is acceptable in the heat treatment step of the current invention.
The irradiated preform preferably is heated at a temperature at or above the onset of melting temperature of the irradiated heat-treated preform material, and preferably at a temperature near or above the peak melting temperature of the irradiated heat-treated polymer for a time of 2-120 hours, preferably 5-60 hours, more preferably 12-60 hours. The onset of melting temperature is defined herein as the temperature at the intersection of the baseline and steepest negative slope of the DSC melting endotherm. The baseline intersects the initial portion of the melting endotherm and is tangent to the final portion of the curve. The peak melting temperature is defined herein as the location of the peak of the melting endotherm. The onset of melting temperature for irradiated, heat-treated UHMWPE is generally about 120° C. and the peak melting temperature is generally between 135° C. and 140° C. An especially preferred embodiment of the current invention is irradiation with a dose of 1.5-6 Mrads followed by heat treatment at 150-170° C. for a period of 6-60 hours, more preferably 12-60 hours. The temperature and hold time that is sufficient to react substantially all of the free-radicals may be determined by measuring the oxidation of the samples using the method described below. Preferably, the temperature and hold time are chosen such that oxidation levels of less than about 0.2 carbonyl area/mil sample thickness, preferably less than about 0.1 carbonyl area/mil sample thickness, after aging as measured by this method are obtained. Heat treatment at or above the onset of melting temperature results in improved molecular mobility and elimination of free radicals in the crystalline regions of the polymer and increased cross-linking and reduced oxidation in aged samples. When heat treatment is carried out at lower temperatures, elimination of free radicals is less complete resulting in higher levels of residual oxidation upon aging.
Standard UHMWPE may be irradiated and pressure recrystallized to convert the UHMWPE into an extended chain conformation by conducting the heat treatment step using the temperatures and pressures disclosed for pressure recrystallization in U.S. Pat. No. 5,478,906. In pressure recrystallizing UHMWPE, the polymer is placed in a pressure vessel in water and enough pressure to withstand the pressure the water will develop at the operating temperatures. The temperature of the vessel is raised to melt the polyethylene which generally melts at 135-150° C. at one atmosphere, and about 200° C. at 50,000 psi. The time required to melt the polymer depends on the size of the UHMWPE preform used. Because UHMWPE is a poor heat conductor and has a very high heat of crystallization, it can take 1-2 hours to heat a 3 in. diameter rod to 200° C. with the vessel at 220° C. Once the polymer is hot and molten, the pressure is applied. Preferred pressures are about 33 kpsi (230 MPa) to 70 kpsi (480 MPa). Further improvement in properties may be achieved by annealing the UHMWPE in an inert atmosphere at temperatures above the melting point prior to pressure recrystallization. Pressures of greater than 45 kpsi (310 MPa) are preferred for pressure recrystallization of material which is pre-annealed prior to pressure recrystallization. The cooling time normally is about 6 hours from 250° C. to 75° C., but forced cooling of the vessel can reduce this to 1-2 hours with no adverse effects on the product.
Preferably, the UHMWPE material prepared according to the process of the current invention is an isotropic material, with no significant molecular or crystalline orientation. In order to prevent inducing residual stress in the polymer, thermal treatment after irradiation is preferably performed in such a manner that no non-uniform forces which could lead to deformation of the material during heat treatment will occur. During heat treatment the preform can be subjected to uniform pressure, such as isostatic or hydrostatic pressure, or alternatively, the preform can be heated in the absence of any externally applied pressure, so as to not deform the UHMWPE. It is undesirable to deform the preform by application of compressive or other forces as this results in an oriented material which may deform due to internal stresses after machining of the implant.
After a predetermined time, the cross-linked preform is cooled while still in an inert atmosphere or vacuum. The cross-linked preform is cooled to a temperature less than about 100° C., preferably less than about 50° C., more preferably to room temperature, prior to exposing the preform to air. If the preform was packaged during the heat treatment step, after cooling it is removed from the packaging and formed into an implant using methods known in the art such as machining. The cross-linked UHMWPE is especially useful as a bearing surface, for example in prosthetic hip joint cups and as other prosthetic shapes for replacement of other joints of the human body, including knees, shoulders, fingers, spine, and elbows. The finished implant is then packaged and sterilized using non-radical-forming methods. Because the implant is oxidatively stabilized, it is not necessary to package the finished implant in an inert atmosphere. For example, the implant can be packaged in air-permeable packaging and sterilized using gas plasma or ethylene oxide methods which are known in the art. For example a PLAZLYTE® gas plasma sterilization unit, manufactured by Abtox (Mundelein, Ill.), may be used.
In an alternate embodiment of the current invention, the UHMWPE preform is pre-annealed prior to the irradiation step. In the pre-annealing step, the preform is subjected to a temperature of 280° C.-355° C., preferably 320° C.-355° C., for at least 0.5 hour, preferably at least 3 hours, in an inert atmosphere, without the application of external pressure. It is generally desirable to heat the polymer as close as possible to, without reaching, its decomposition temperature. The pre-annealed preform is then cooled non-precipitously to a temperature of about 130° C. or below, the rate of cooling being such that temperature gradients producing internal stresses in the article are substantially avoided. Rapid cooling, such as by immersion in cold water, should be avoided as it causes internal voids to form. It is generally convenient to allow the polymer to cool wrapped in insulation. The pre-annealed preform has improved elongation, impact resistance, and crystallinity over the starting UHMWPE. The cooled pre-annealed preform is then irradiated and annealed as described above.
TEST METHODS
Unless noted otherwise , test specimens were prepared from the interior of the preform rods.
Type IV tensile specimens comforming to ASTM D-638 were machined from the UHMWPE sample materials. The test specimens were mounted in a Lloyd LR10K mechanical test frame and tested for the tensile yield stress (TYS), ultimate tensile stress (UTS) and percent elongation according to ASTM D-638. Type IV specimens were used to measure UTS, TYS, and percent elongation for Examples 1-27, and Comparative Examples A-C.
Type I tensile specimens were machined from the UHMWPE samples and mounted in the test frame. Tensile modulus was measured on these samples according to ASTM D-638. Type I tensile specimens were also used to measure TYS, UTS and percent elongation for Examples 28-37 and Comparative Example D.
All tensile properties represent the average of 5 test specimens.
Thermal analysis was performed on disks approximately 3 mm thick and 1.5 mm in diameter which were cut from the UHMWPE sample rod. The disk was placed in a differential scanning calorimetry (DSC) sample pan and weighed. The lid was placed on the pan and crimped in place. The pan was placed in a DuPont Model 2000 thermal analyzer and allowed to equilibrate at a temperature of 50° C. It was then heated at a rate of 20 degrees C./minute. The peak melting point was taken as the location of the peak of the melting endotherm. The onset of melting temperature was determined from the DSC curve as the intersection of the baseline and the steepest negative slope of the melting endotherm. The baseline intersects the initial portion of the melting endotherm and is tangent to the final portion of the curve. The heat of fusion (Hf) was calculated as the area of the melting endotherm.
The percent crystallinity was determined by dividing the measured heat of fusion by the theoretical heat of fusion of crystalline UHMWPE, 290 J/g.
Density measurements were performed on 1.5 mm thick disks of UHMWPE cut from the UHMWPE sample rods. The disks were soaked in a 65/35 solution by weight of 2-propanol, histological grade, and water. The sample was placed into a calibrated density gradient column. The density was determined from the equilibrium position of the sample in the column and is reported as g/cc.
Resistance to deformation (creep) was measured in accordance with ASTM D-621 with the following modifications: samples machined into cylinders or cubes without the use of lubricating liquids; samples measured 0.5 in.×0.5 in. ×0.5 in.
Impact resistance was measured using the notched Izod test given in ASTM D-256 with the following modifications: samples machined into shape without the use of lubricating liquid; type A or notched IZOD; specimen size was 0.5 in.×2.5 in.; 0.4 in. from bottom of vertex to opposite side; 1.25 in. impacted end (from end of bar to vertex of notch); the notch should be the specified angle of 22.5 degrees. Impact strength was also measured using double notched Izod specimens and the test method described in ASTM F-648 Annex A1.
Oxidative aging was performed on specimens which were wrapped in porous breather fabric to prevent close packing of the specimens and allow free gas access to all surfaces. The specimens were then loaded into a 4 in.×8 in. cylindrical pressure bomb and sealed. The bomb was pressurized to 5 atmospheres (73.5 psi) with oxygen and heated with cylindrical band heaters to 70° C. and held for 14 days. Aged wear test results were obtained by aging the hip cups using this procedure prior to wear testing. Similarly, aged Izod specimens for double notch impact strength measurements were prepared according to ASTMF-648 Annex A1 followed by oxidative aging prior to strength measurements.
Specimens for oxidation measurements were cut from the interior of the cooled preform rods after gamma-irradiation and annealing. The samples were 45 degree wedge cuts from 0.5 inch thick by 2.5 inch diameter disks. Oxidation measurements were made on 250 micron thick sections prepared by cutting the wedge-shaped specimens through their thickness using a band saw. A 250 micron thick slice was microtomed off the freshly exposed surface and analyzed using FTIR. Aged oxidation results were obtained from wedge cuts that were aged according to the oxidative aging procedure described above prior to preparing the 250 micron thick section. The sample was mounted in a Digilab FTIR fitted with a microscope with a motorized stage. The FTIR aperture was focused through the microscope to allow measurement of the infrared absorbance in a small (25 micron×200 micron) section of the sample. The microscope stage was moved by a stepper motor in increments of 50 microns to measure the carbonyl absorbance at a number of locations from the surface down to a depth of 4 mm. Oxidation was quantified based on the absorbance of the carbonyl peaks at 1670-1730 wavenumbers as compared to a reference peak corresponding to methylene stretching along the polymer backbone at 4250 wavenumber using the method of Nagy & Li, A Fourier Transform Infrared Technique For The Evaluation of Polyethylene Bearing Materials, Transactions, 16th Annual Meeting, The Society for Biomaterials, 3:109, 1990. An average oxidation level was calculated by integrating the carbonyl concentration versus depth curve to a depth of 2.05 mm. Oxidation is reported as carbonyl area/mil sample thickness.
Swell ratios were measured per ASTM D 2765 method C. The test specimens were 0.32 inch cubes. All swell ratios represent the average of 4 test specimens.
Gas plasma sterilization was performed by (a) placing the component in a breathable pouch and heat sealing, (b) placing the packaged components in the chamber of a PLAZLYTE® Sterilization System (Abtox, Inc., Mundelein, Ill.) and evacuating (c) filling the chamber with peracetic acid vapor and holding for a predetermined time, (d) evacuting the chamber, (e) filling the chamber with a filtered secondary plasma and holding for a predetermined time, (f) evacuating the chamber, (g) repeating steps (c)-(f), (h) filling the chamber with atmospheric air, (i) evacuating the chamber, and (3) repeating steps (h) and (i) to complete the cycle.
Wear rates were obtained by mounting test hip cups having a 28 mm spherical hole in the cup in a hip simulating wear tester which included 28 mm diameter femoral heads. The test cups were machined from the interior of the preform rods and were pre-soaked for 30 days in bovine calf serum solution containing 20 mM EDTA and 0.2 wt % sodium azide. The cups were sterilized by gas plasma prior to wear testing. The wear tester simulated the human gait using the Paul hip curve at a 1900 N peak load and a frequency of 1.1 Hz. The load is applied in the vertical direction. The test cup in the hip simulator is immersed in bovine calf serum and angled at 23 degrees from the horizontal. Every 500,000 cycles, the cups are washed, dried and weighed. Each test was run between 2.5 and 5 million cycles. Soak controls cups were used to correct for fluid absorption. The wear rate is the soak corrected change in cup weight per million cycles.
EXAMPLES
In each of Examples 1-3, 28-37, and Comparative Examples A-D, the UHMWPE preform comprised GUR 4150 HP ram-extruded UHMWPE (PolyHi Solidur, Fort Wayne, Ind.) in the form of 3.5 in. (8.9 cm) diameter rods approximately 30 in. (76.2 cm) in length. This polymer has a molecular weight of approximately 6 million, a peak melting point of about 135° C., and a percentage crystallinity of about 45-55%.
Examples 1-3
Rods of UHMWPE as described above were placed in separate pouches of heat sealable packaging foil having a MYLAR® polyester coating, SP Class E style 1.40 sleevestock (Shield Pack, Inc., West Monroe, La.), flushed with nitrogen and then evacuated. This procedure was repeated and the pouches were then sealed under vacuum. The rod of Example 1 was irradiated with a dose of 1 Mrad of gamma irradiation from a Cobalt-60 source. Gamma irradiation was performed by Isomedix (Morton Grove, Ill.). The rods of Examples 2 and 3 were irradiated with doses of 2.5 Mrads and 5 Mrads, respectively. After irradiation, the packaged rods were placed individually in an oven at a temperature of 325° C. and held at that temperature for 4.5 hours. At the end of 4.5 hours, the rods were cooled in the oven at about 20° C./hr to ambient temperature in their packages. The cooled rods were then removed from their packages and mechanical and physical properties and oxidation were measured as described above. The results and process conditions are shown in Table I. These examples show excellent oxidation resistance under both aged and unaged conditions compared to Comparative Examples A, B, and C. The effect is greatest for Example 3 (vs. Comparative Example C) which was irradiated at the higher dose of 5 Mrads. Aged and unaged oxidation resistance for Examples 1-3 is comparable to unirradiated Example D. This improved performance is due to the substantially complete quenching of the free radicals by annealing at 325° C. These examples also shown an unexpected benefit of a large increase, approximately 2×, in the % elongation to break, attributed to the temperature of the annealing. Elongation generally increases significantly for samples which are annealed or pre-annealed at temperatures of greater than about 280° C.
Comparative Examples A-C
UHMWPE rods for comparative Examples A and C were packaged under vacuum as described in Examples 1-3, and irradiated at doses of 1 Mrad and 5.0 Mrad, respectively. The rod of Comparative Example B was irradiated with 2.5 Mrad in air without packaging. The rods were not heat-treated after irradiation. Mechanical and physical properties and oxidation were measured as described above. The results and process conditions are shown in Table I. Test specimens were taken from the interior of the rod, thus substantially eliminating any effects of oxidation in comparative Example B which was irradiated in air. For Example B, an unaged wear rate of 15 mg/million cycles and an aged wear rate of 88 mg/million cycles were measured after 5 million cycles. These examples show oxidative degradation in the accelerated aged state, demonstrating the reaction of unquenched free radicals with oxygen. Example B also shows the effect of this oxidation on impact strength and wear. Impact strength is reduced by a factor of 10 after aging. Although the unaged wear rate for Example B is improved compared to Comparative Example D, the wear rate is increased by nearly 6× after aging, significantly higher than the wear rate for Comparative Example D.
Comparative Example D
The UHMWPE rods for this example were not irradiated, heat treated or pressurized. They were gas plasma sterilized by a PLAZLYTE® Sterilization System (Abtox Inc., Mundelein, Ill.). The mechanical and physical properties are similar to commercially available UHMWPE rods and are shown in Table V. An unaged wear rate of 30 mg/million cycles and an aged wear rate of 33 mg/million cycles were obtained after 5 million cycles.
Examples 4-15
Hoechst GUR 415 UHMWPE in the form of 3 in. (7.6 cm) diameter rods obtained from PolyHi Solidur were cut to about 15 in. (38.1 cm) length and sealed in polyethylene lined aluminum foil bags under a nitrogen atmosphere.
The rods were irradiated with Co-60 gamma rays and aged for one month in the sealed bags to permit the free radicals to react. Irradiation doses of 0.5, 1, 2, and 5 Mrad were used. The bars were then removed from the bags and immediately placed in a pressure vessel, as described in Simmons et al. U.S. Pat. No. 5,236,669, which patent is hereby incorporated by reference. Pressure recrystallization was conducted by sealing the vessel and pressurizing with water to about 5000 psi. The vessel was then heated over a period of 1.5 hours to 250° C. After 2 hours, the pressure was raised to 50,000 psi and maintained there for the rest of the pressure treatment. After 1 to 2 hours at 250° C., the vessel was allowed to cool to 75° C. at which point the pressure was released and the product recovered. Additional rods were also pressure recrystallized using the above procedure at 39,000 and 34,000 psi. The results are shown in Table II.
Examples 16-21
In these examples, the 3 in. diameter GUR 415 UHMWPE rods were pre-annealed at 325° C. for 4.5 hours in nitrogen, cooled in nitrogen at approximately 20° C./hr, and then sealed in aluminum foil/polyethylene bags under nitrogen. The bars were then irradiated with gamma rays. After aging one month, the polymers were pressure recrystallized as described above. Process conditions and results are given in Table III. The polymer was converted to extended chain form only at higher pressure. The samples treated with 50,000 psi during pressure recrystallization had higher melting points, higher heats of fusion, higher tensile moduli, higher maximum strengths, higher tensile strength at yield, higher Izod impact strength, and improved creep resistance.
The pre-annealed samples of Examples 16-21 have higher elongations than the corresponding samples of Examples 4, 5, 7, 8, 10 and 11 which were not pre-annealed.
Examples 22-23
In these examples, 3 in. diameter GUR 415 UHMWPE rods were gamma irradiated at 2.5 Mrad and 5.0 Mrad in nitrogen and pressure recrystallized at 39,500 psi using the process described in Examples 4-15. Irradiation conditions and results are given in Table IV.
Examples 24-25
In these examples, 3 in. diameter GUR 415 UHMWPE rods were gamma irradiated at 2.5 Mrad and 5 Mrad, and then subjected to pressure recrystallization at 33,500 psi using the process described in Examples 4-15. Irradiation conditions and results are given in Table IV.
Examples 22-23 and 24-25 show excellent oxidation resistance in both the aged and unaged states as did Examples 1-3, also due to substantially complete quenching of free radicals during the pressure recrystallization step. The samples also show increased crystallinity, which in turn shows that it is possible to change the crystal structure of the polymer even in the presence of crosslinks.
Examples 26-27
In these examples, 3 in. diameter GUR 415 UHMWPE rods were pre-annealed in nitrogen at 325° C. for 4.5 hours prior to gamma irradiation, cooled at approximately 20° C./hr, followed by gamma irradiation under nitrogen at 2.5 Mrad and 5 Mrad, and then subjected to pressure recrystallization at 39,500 psi using the process described in Examples 4-15. Irradiation conditions and results are given in Table IV. These examples show that by combining a pre-annealing step (325° C.) with pressure recrystallization after irradiation, oxidation resistance is maintained, the elongation is increased and the crystallinity increased compared to conventional UHMWPE (Comparative Example D).
Example 28-30
UHMWPE rods 28-30 were packaged and processed as described in Example 2 (2.5 Mrad) except that the rods were heated at 155° C. for 6, 24, and 48 hours respectively, removed from the oven and cooled. The process conditions, mechanical and physical properties are shown in Table V. These examples show that annealing at 155° C. creates a material with excellent oxidation resistance. Irradiated samples 28-30 exhibited a reduction in double notched Izod compared to the unirradiated Comparative Example D. It also shows that the crosslinking produced by the 2.5 Mrad radiation dose yields a swell ratio of 3.9 as compared to 24.1 for Example D. An unaged wear rate of 14 mg/million cycles was measured after 5 million cycles for hip cups prepared from the cross-linked polymer of Example 30.
Examples 31-33
UHMWPE rods 31, 32 and 33 were packaged and processed as described in Example 3 (5 Mrad) except that the rods were heated to 155° C. for 6, 24 and 48 hours respectively, removed from the oven, and cooled. The process conditions, mechanical and physical properties are shown in Table V. These examples show that UHMWPE exposed to 5 Mrads of gamma irradition then annealed at 155° C. also gives excellent oxidation resistance. It also shows that the radiation dose reduces the impact strength and the elongation. A comparison of these swell ratios, 2.6, with Examples 28-30 and D, show that crosslinking is increased with radiation dose. An unaged wear rate of 0.8 mg/million cycle and an aged wear rate of 0.6 mg/million cycles were measured for Example 32 after 2.5 million cycles. The wear rate of Example 32 is greatly reduced compared to Examples 30, B and D. By performing both the irradiation and annealing steps, the wear and oxidation resistance of this material is greatly improved over material that is irradiated but not annealed. Oxidation resistance is comparable to unirradiated polymer (Comparative Example D) and wear performance is significantly improved.
Example 34-36
UHMWPE rods 34, 35 and 36 were packaged and processed as described in Example 3 (5 Mrad) except that the rods were heated to 200° C. for 6, 24 and 48 hours respectively, removed from the oven and cooled. The process conditions, mechanical and physical properties are shown in Table V. These examples show that annealing at 200° C. is also effective for producing an oxidation resistant material.
Example 37
This rod was packaged and processed as described in Example 3 (5 Mrad) except the rod was heated to 120° C. for 48 hours, removed from the oven, and cooled. An unaged wear rate of 5 mg/million cycles was measured after 5 million cycles. Results are shown in Table V. This example shows the improved wear resistance of a material crosslinked at 5 Mrads and annealed at 120° C. for 48 hours as compared to Examples 30 (2.5 Mrad, 155° C./48 hrs), C (5 Mrad, unannealed), and D (unirradiated).
TABLE I
Example 1 2 3 A B C D
Gamma dose (Mrad) 1 2.5 5 1 2.5 5 0
Hold Temp/Time (deg C./hr) 325/4.5 325/4.5 325/4.5 none none none none
Mechanical Properties
Type I Samples
Modulus (kpsi) 147.8 148.5 144.3 143.1 137.0
Secant Modulus (kpsi) 122.3
Type IV Samples
TYS 3.544 3.454 3.429 3.553 3.507 3.669 3.396 (Type I)
UTS 5.603 5.481 5.644 5.324 5.47 5.511 5.15 (Type I)
% Elongation 805 700 613 310 340 267 343 (Type I)
Impact Strength - Double Notched Izod (Ft-lb/sq in)
(unaged) 48.1 48.1
(aged) 4.8
Physical Properties
Density (g/cc) 0.9461 0.9442 0.9409 0.9356 0.9378 0.9379 .9344
Hf (J/g) 170.9 184.2 161.6 145 163.3 165.8
% Crystallinity 58 63 55 50 56 57 51
Peak Tm (° C.) 138.1 137.1 135.6 139.4 138.7 137.4 136.7
Onset of melting T (° C.) 126.0 125.8 123.0 127.2 130.8
Oxidation (unaged) 0.067 0.048 0.068 0.154 0.172 0.398 .054
oxidation (aged) 0.14 0.078 0.117 0.527 1.107 2.78 .075
Swell Ratio 24.1
Wear Rate (mg/million cycles)
(unaged) 15 30
(aged) 88 33
TABLE II
Example 4 5 6 7 8 9 10 11 12 13 14 15
Gamma 0.5 0.5 0.5 1 1 1 2 2 2 5 5 5
Dose (Mrad)
Pressure (kpsi) 50 39 34 50 39 34 50 39 34 50 39 34
Tensile
Strength, psi
Yield 3877 3668 3504 3804 3543 3470 3597 3524 3446 3628 3553 3394
Max 5871 6400 5936 6662 6463 5514 6551 5517 5047 5766 5205 5155
Break 5629 6397 4791 6570 5759 4995 6054 4462 5023 4877 5204 4220
Modulus (kpsi) 288.4 272.8 229.3 248.3 239.0 227.8 309.1 250.3 292.4 237.7 234.1 188.1
Elongation, %
Yield 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5
Break 290 309 232 296 324 311 272.7 289.5 286.3 243 247 254
IZOD 19.6 20.1 19.8 19.7 19.6 19.1 19.8 19.8 18.7 19.4 17.4 17.9
ft lb/in of notch
Deformation (%) 1.0 1.5 1.6 1.6 1.7 1.9 1.7 1.7 1.9 1.8 1.9 1.8
24 hrs., 23 deg. C.,
1000 psi.
DSC
Peak mp, deg C. 147.6 144.8 138.3 147.6 147.3 137.2 150.4 150.4 145.5 146.0 145.7 147.7
Hf (J/g) 185.7 170.4 133.7 185.7 173.6 53.7 171.3 171.3 170.4 178.5 183.9 187.2
Peak mp, deg C.* S S 145 S S 143.9 S S S S
Hf (J/g) 58.4 125.2
(*S stands for shoulder on low temperature side of DSC curve)
TABLE III
Physical Properties of Pre-Annealed (325° C.) UHMWPE,
Gamma Irradiated and Pressure Recrystallized
Example 16 17 18 19 20 21
Dose (Mrad) 0.5 0.5 1 1 2 2
Pressure 50 39 50 39 50 39
(kpsi)
Tensile Strength, psi
Yield 4277 3773 4066 3543 4051 3594
Max 5289 4696 5145 4332 5142 4119
Break 4532 4695 4582 4331 4604 4117
Modulus (kpsi) 335.2 276.0 296.9 219.0 293.6 266.5
Elongation, %
Yield 5 7.5 5 7.5 7.5
Break >432 >500 >450 417 >400 388
IZOD 24.0 20.5 24.2 21.6 23.6 21.9
(ft lb/in of notch)
Deformation (%) 0.7 2.8 0.8 1.8 1.2 2.3
24 hrs, 23 deg C., 1000 psi
DSC
mp, deg C. 148.8 140.7 148.9 140.8 148.6 140.8
Hf (J/g) 217 175 207 185.9 202.8 177.9
TABLE IV
Example 22 23 24 25 26 27
Gamma dose 2.5 5 2.5 5 2.5 5
(Mrad)
Pre-annealing
Heat/hold time none none none none 325/4.5 325/4.5
(deg C./hrs)
Pressure (psi) 39,500 39,500 33,500 33,500 39,500 39,500
MECHANICAL PROPERTIES
Type I Samples
modulus (kpsi) 172.6 171.5 153.7 151.2 144.3 187.5
Secant modulus 157 146.9 136.8 136.7 178.9 162.1
(kpsi)
Type IV Samples
TYS (kpsi) 3.565 3.591 3.423 3.508 3.926 3.901
UTS (kpsi) 5.855 5.862 5.439 5.475 5.696 5.57
% Elongation 287 258 292 256 525 568
PHYSICAL PROPERTIES
Density (g/cc) 0.9393 0.9396 0.9368 0.9381 0.9475 0.9461
Hf (J/g) 188.7 158.1 150.8 174.4 177.4 176.7
% Crystallinity 65.069 54.517 52 60.138 61.172 60.931
Tm (deg C.) 143.5 143.8 143.1 143.5 134.7 136.3
oxidation (unaged) 0.055 0.082 0.092 0.074 0.082 0.065
oxidation (aged) 0.08 0.082 0.08 0.096 0.133 0.16
TABLE V
Example 28 29 30 31 32 33 34 35 36 37
Gamma dose 2.5 2.5 2.5 5 5 5 5 5 5 5
(Mrad)
Heat/hold time 155/6 155/24 155/48 155/6 155/24 155/48 200/6 200/24 200/48 120/48
(° C./hrs)
MECHANICAL
PROPERTIES
Type 1 Tensile Samples
Modulus (kpsi) 115.7 114.3 124.9 111.9 116.2 110.8 112.4 118.4 108.7
Secant mod. 106.5 104.6 114.3 99.3 104.9 101.8 100.6 109.6 98.5
(kpsi)
TYS (kpsi) 3.080 3.100 3.056 3.068 3.147 3.1#3 3.075 3.115 3.094
UTS (kpsi) 5.130 5.436 5.024 5.037 5.238 5.267 4.698 5.053 5.000
% Elongation 331 326 321 212 273 283 265 263 278
Impact Strength, Double
Notch (ft lb/in2)
(unaged) 44.0 44.7 44.0 36.2 35.1 37.3 37.3 38.3 36.9
(aged) 44.0 44.6 42.7 36.0 35.7 37.8 37.0 36.8 37.1
Deformation (%) 1.5 1.1 1.4 1.2 1.6 1.0 1.0 1.2 1.2
(24 hrs, 23° C., 1 kpsi)
PHYSICAL PROPERTIES
Density (g/cc) 0.9292 .9289 .9298 .9295 .9299 .9292 .9292 .9295 .9285
Hf (J/g) 135.6 146.3 132.5 141.2 128.5 147.4 131.4 142.9 145.8
% Crystallinity 47 50 45 49 44 51 45 49 50
Peak Tm (° C.) 134.7 134.4 135.1 137.8 136.6 134.9 134.8 137.3 135.8
Onset of melting
T, (° C.) 121.8 123.6 122.7 121.3 120.9 120.1 119.9 121.8 120.5
oxidation
(unaged) .067 .052 0.064 0.052 0.053 0.065 0.065 0.055 0.110
(aged) .059 .057 0.076 0.069 0.064 0.081 0.074 0.140 0.082
Swell ratio 3.9 3.3 3.7 2.5 2.6 2.6 2.8 2.4 2.7
Wear rate (mg/million cycles)
(unaged) 14 0.8 5
(aged) 0.6

Claims (25)

What is claimed is:
1. A process for preparing an orthopaedic implant prosthesis bearing having improved mechanical properties and increased wear resistance comprising the steps of:
providing a polyethylene preform from which the bearings are to be fabricated;
heating the preform to a temperature greater than its melting temperature and less than its decomposition temperature for a time sufficient to increase its percent elongation to break properties; and
then, subsequently irradiating the preform.
2. The process of claim 1 wherein the heating step is performed at temperatures from about 280° C. to about 355° C.
3. The process of claim 1 wherein the preform is irradiated with gamma radiation at a dose of about 0.5 to about 10 Mrad.
4. The process of claim 1 wherein the percent elongation is about 250 or greater.
5. The process of claim 1 wherein the percent elongation is about 400 or greater.
6. The process of claim 1 further comprising a heat treatment step subsequent to the irradiation step.
7. A process for preparing an orthopaedic implant prosthesis bearing having an improved balance of wear properties and oxidation resistance comprising the steps of:
providing an ultrahigh molecular weight polyethylene preform from which the bearings are to be fabricated;
heating the preform to a temperature of about 280° C. to about 355° C. for a period of time greater than about 0.5 hours;
cooling the preform to a temperature below the melting temperature to obtain a solid preform;
irradiating the solid preform with about 0.5 to about 10 Mrad of gamma radiation to cross-link the preform; and
quenching the free radicals in the preform.
8. The process of claim 7 wherein the preform is heated at a temperature of about 320° C. to about 355° C. for at least 3 hours.
9. The process of claim 7 wherein the heating step is performed in a substantially oxygen-free atmosphere.
10. The process of claim 7 wherein the preform is cooled at a rate of about 40° C./hr or less.
11. The process of claim 7 wherein the preform is insulated while cooled.
12. The process of claim 7 wherein the preform is cooled to about 130° C. or less.
13. The process of claim 7 wherein the preform is irradiated with gamma radiation at a dose of about 1.5 to about 6 Mrad.
14. The process of claim 7 wherein the radical quenching step is conducted in a substantially oxygen-free atmosphere.
15. The process of claim 7 wherein the radicals are quenched by annealing the preform at about its peak melting temperature or greater.
16. The process of claim 7 wherein the radicals are quenched by annealing the preform at a temperature of about 135° C. or greater for up to about 120 hours.
17. The process of claim 7 wherein the radicals are quenched by annealing the preform at a temperature of about 150° C. to about 170° C. for up to about 60 hours.
18. The process of claim 7 wherein the radicals are quenched by aging the preform in an substantially oxygen-free atmosphere for at least 1 month.
19. The process of claim 18 which further comprises placing the preform in an oxygen-impermeable package.
20. The process of claim 7 wherein the radicals are quenched via pressure crystallization.
21. The process of claim 20 wherein the pressure crystallization is performed at about 33,000 to about 70,000 psi at about 250° C.
22. The process of claim 7 wherein the radical quenching step is performed for a time sufficient to form a cross-linked preform having an oxidation level of 0.2 carbonyl area/mil sample thickness or less after aging the cross-linked preform at about 70° C. for about 14 days in oxygen at a pressure of about 5 atmospheres.
23. A process for preparing an orthopaedic implant prosthesis bearing having an improved balance of wear properties and oxidation resistance comprising the steps of:
providing an ultrahigh molecular weight polyethylene preform from which the bearings are to be fabricated;
heating the ultrahigh molecular weight polyethylene preform to a temperature of about 280° C. to about 355° C. for a period of about 0.5 hours or greater;
irradiating the preform to cross-link the preform with gamma radiation at a dose of about 1.5 to about 6 Mrad;
quenching the free radicals in the preform by annealing the preform at a temperature of about 150° C. to about 170° C. for up to about 60 hours;
cooling the cross-linked preform; and
forming a bearing from the cross-linked preform.
24. The process of claim 23 wherein the heating step is performed at about 325° C. for about 4.5 hours.
25. A process for preparing an orthopaedic implant prosthesis bearing having improved mechanical properties and increased wear resistance comprising the steps of:
providing a polyethylene preform from which the bearings are to be fabricated;
irradiating the preform; and
heating the preform to a temperature greater than its melting temperature and less than its decomposition temperature for a time sufficient to increase its percent elongation to break properties.
US09/688,551 1996-10-02 2000-10-16 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance Expired - Lifetime US6316158B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/688,551 US6316158B1 (en) 1996-10-02 2000-10-16 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US10/056,684 US6562540B2 (en) 1996-10-02 2001-10-29 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2735496P 1996-10-02 1996-10-02
US08/911,792 US6017975A (en) 1996-10-02 1997-08-15 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US09/422,722 US6242507B1 (en) 1996-10-02 1999-10-22 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US09/688,551 US6316158B1 (en) 1996-10-02 2000-10-16 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/422,722 Continuation US6242507B1 (en) 1996-10-02 1999-10-22 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/056,684 Continuation US6562540B2 (en) 1996-10-02 2001-10-29 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance

Publications (1)

Publication Number Publication Date
US6316158B1 true US6316158B1 (en) 2001-11-13

Family

ID=26702366

Family Applications (4)

Application Number Title Priority Date Filing Date
US08/911,792 Expired - Lifetime US6017975A (en) 1996-10-02 1997-08-15 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US09/422,722 Expired - Lifetime US6242507B1 (en) 1996-10-02 1999-10-22 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US09/688,551 Expired - Lifetime US6316158B1 (en) 1996-10-02 2000-10-16 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US10/056,684 Expired - Lifetime US6562540B2 (en) 1996-10-02 2001-10-29 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US08/911,792 Expired - Lifetime US6017975A (en) 1996-10-02 1997-08-15 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US09/422,722 Expired - Lifetime US6242507B1 (en) 1996-10-02 1999-10-22 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/056,684 Expired - Lifetime US6562540B2 (en) 1996-10-02 2001-10-29 Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance

Country Status (6)

Country Link
US (4) US6017975A (en)
EP (1) EP0935474B1 (en)
JP (2) JP5014528B2 (en)
AU (1) AU4742697A (en)
DE (1) DE69737356T2 (en)
WO (1) WO1998014223A1 (en)

Cited By (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6464926B1 (en) 1996-02-13 2002-10-15 The General Hospital Corporation Process of making ultra high molecular weight polyethylene prosthetic devices
US20020156536A1 (en) * 1996-02-13 2002-10-24 Harris William H. Polyethylene hip joint prosthesis with extended range of motion
US20030050703A1 (en) * 2000-07-31 2003-03-13 Harris William H. Acetabular components that decrease risks of dislocation
US20030083433A1 (en) * 2001-10-30 2003-05-01 James Susan P. Outer layer having entanglement of hydrophobic polymer host and hydrophilic polymer guest
US20030105182A1 (en) * 1996-02-13 2003-06-05 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
WO2003049930A1 (en) * 2001-12-12 2003-06-19 Depuy Products, Inc. Orthopaedic device and method for making same
EP1332735A1 (en) 2002-01-28 2003-08-06 Depuy Products, Inc. Composite prosthetic bearing having a crosslinked articulating surface and method of manufacture
US20030149125A1 (en) * 2002-01-04 2003-08-07 Muratoglu Orhun K. High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US6641617B1 (en) 1996-02-13 2003-11-04 The General Hospital Corp. Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method
US20030212161A1 (en) * 2000-04-27 2003-11-13 Mckellop Harry A Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US6652586B2 (en) * 2001-07-18 2003-11-25 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US20040111160A1 (en) * 2001-07-18 2004-06-10 Evans David L. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US6800670B2 (en) 1996-07-09 2004-10-05 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US20040210316A1 (en) * 2003-04-15 2004-10-21 Richard King Implantable orthopaedic device and method for making the same
US20040266903A1 (en) * 2003-06-30 2004-12-30 Depuy Products, Inc. Free radical quench process for irradiated ultrahigh molecular weight polyethylene
US20040265165A1 (en) * 2003-06-30 2004-12-30 Depuy Products, Inc. Free radical quench process for irradiated ultrahigh molecular weight polyethylene
EP1520877A1 (en) 2003-09-30 2005-04-06 Depuy Products, Inc. Medical implant or medical implant part with ultrahigh molecular weight polyethylene and at least one hydrophilic polymer
EP1618902A1 (en) * 2004-06-30 2006-01-25 DePuy Products Low crystalline polymeric material for orthopaedic implants
US20060142449A1 (en) * 2004-12-23 2006-06-29 Depuy Products, Inc. Polymer composition comprising cross-linked polyethylene and methods for making the same
EP1720485A2 (en) * 2004-02-03 2006-11-15 The Massachusetts General Hospital Highly crystalline cross-linked oxidation-resistant polyethylene
US7186364B2 (en) 2002-01-28 2007-03-06 Depuy Products, Inc. Composite prosthetic bearing constructed of polyethylene and an ethylene-acrylate copolymer and method for making the same
CZ297700B6 (en) * 2005-12-13 2007-03-07 Ústav makromolekulární chemie AV CR Modification method of ultra high-molecular polyethylene for manufacture of joint prostheses with increased service life
US20070067044A1 (en) * 2005-09-22 2007-03-22 Depuy Products, Inc. Orthopaedic bearing material
US20070077268A1 (en) * 2005-09-30 2007-04-05 Depuy Products, Inc. Hydrophobic carrier modified implants for beneficial agent delivery
US20070232761A1 (en) * 2006-03-31 2007-10-04 Depuy Products, Inc. Bearing material of medical implant having reduced wear rate and method for reducing wear rate
US7344672B2 (en) 2004-10-07 2008-03-18 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US20080197541A1 (en) * 2005-06-14 2008-08-21 Omni Life Science, Inc Crosslinked Polyethylene Article
US7462318B2 (en) 2004-10-07 2008-12-09 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US20080318022A1 (en) * 2001-10-30 2008-12-25 Colorado State University Research Foundation (Csurf), Colorado Non-Profit Outer layer material having entanglement of hydrophobic polymer host blended with a maleated hydrophobic polymer co-host, and hydrophilic polymer guest
US7547405B2 (en) 2004-10-07 2009-06-16 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US20100036491A1 (en) * 2008-08-05 2010-02-11 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US7683133B2 (en) 2006-08-25 2010-03-23 Depuy Products, Inc. Bearing material of medical implant and methods for making it
US7781526B2 (en) 2003-09-19 2010-08-24 Depuy Products, Inc. Medical implant or medical implant part comprising porous UHMWPE and process for producing the same
US7819925B2 (en) 2002-01-28 2010-10-26 Depuy Products, Inc. Composite prosthetic bearing having a crosslinked articulating surface and method for making the same
EP2272542A2 (en) 2001-02-23 2011-01-12 Smith and Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for use as medical implant
US7879275B2 (en) 2004-12-30 2011-02-01 Depuy Products, Inc. Orthopaedic bearing and method for making the same
US7883653B2 (en) 2004-12-30 2011-02-08 Depuy Products, Inc. Method of making an implantable orthopaedic bearing
US20110035017A1 (en) * 2007-09-25 2011-02-10 Depuy Products, Inc. Prosthesis with cut-off pegs and surgical method
US7896921B2 (en) 2004-12-30 2011-03-01 Depuy Products, Inc. Orthopaedic bearing and method for making the same
EP2316382A1 (en) 2009-10-30 2011-05-04 DePuy Products, Inc. Prosthesis for cementless fixation
EP2316383A1 (en) 2009-10-30 2011-05-04 DePuy Products, Inc. Prosthesis with surfaces having different textures
EP2316384A1 (en) 2009-10-30 2011-05-04 DePuy Products, Inc. Prosthesis with modular extensions
EP2319460A1 (en) 2009-10-30 2011-05-11 DePuy Products, Inc. Prosthesis with cut-off pegs
EP2319462A1 (en) 2009-10-30 2011-05-11 DePuy Products, Inc. Prosthesis with composite component
EP2384774A2 (en) 2010-05-07 2011-11-09 Howmedica Osteonics Corp. Surface crosslinked polyethylene
US8128703B2 (en) 2007-09-28 2012-03-06 Depuy Products, Inc. Fixed-bearing knee prosthesis having interchangeable components
WO2012051397A1 (en) 2010-10-14 2012-04-19 Depuy Products, Inc. Prosthesis with surfaces having different textures and method of making the prosthesis
US8187335B2 (en) 2008-06-30 2012-05-29 Depuy Products, Inc. Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US8192498B2 (en) 2008-06-30 2012-06-05 Depuy Products, Inc. Posterior cructiate-retaining orthopaedic knee prosthesis having controlled condylar curvature
US8206451B2 (en) 2008-06-30 2012-06-26 Depuy Products, Inc. Posterior stabilized orthopaedic prosthesis
US8236061B2 (en) 2008-06-30 2012-08-07 Depuy Products, Inc. Orthopaedic knee prosthesis having controlled condylar curvature
US8262976B2 (en) 2004-10-07 2012-09-11 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US8563623B2 (en) 1996-02-13 2013-10-22 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
US8632600B2 (en) 2007-09-25 2014-01-21 Depuy (Ireland) Prosthesis with modular extensions
US8641959B2 (en) 2007-07-27 2014-02-04 Biomet Manufacturing, Llc Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US8715359B2 (en) 2009-10-30 2014-05-06 Depuy (Ireland) Prosthesis for cemented fixation and method for making the prosthesis
US8828086B2 (en) 2008-06-30 2014-09-09 Depuy (Ireland) Orthopaedic femoral component having controlled condylar curvature
EP2777624A1 (en) 2013-03-15 2014-09-17 DePuy Synthes Products, LLC Orthopaedic prosthesis
US9011547B2 (en) 2010-01-21 2015-04-21 Depuy (Ireland) Knee prosthesis system
WO2015095009A1 (en) 2013-12-17 2015-06-25 Depuy (Ireland) Low profile mobile/fixed prosthetic knee systems
US9119723B2 (en) 2008-06-30 2015-09-01 Depuy (Ireland) Posterior stabilized orthopaedic prosthesis assembly
EP2921186A1 (en) 2014-03-21 2015-09-23 Howmedica Osteonics Corp. Annealing method for cross-linked polyethylene
US9168145B2 (en) 2008-06-30 2015-10-27 Depuy (Ireland) Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US9181409B2 (en) 2002-06-06 2015-11-10 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US9204967B2 (en) 2007-09-28 2015-12-08 Depuy (Ireland) Fixed-bearing knee prosthesis having interchangeable components
US9492280B2 (en) 2000-11-28 2016-11-15 Medidea, Llc Multiple-cam, posterior-stabilized knee prosthesis
US9586370B2 (en) 2013-08-15 2017-03-07 Biomet Manufacturing, Llc Method for making ultra high molecular weight polyethylene
EP3300698A1 (en) 2016-09-28 2018-04-04 DePuy Synthes Products, Inc. Method of texturing prosthetic implants
CN111653718A (en) * 2020-07-24 2020-09-11 天津市捷威动力工业有限公司 Polyethylene diaphragm for high-energy-density lithium ion battery, preparation method and application
US10967100B2 (en) 2009-02-20 2021-04-06 The General Hospital Corporation Methods of making a layered consolidated UHMWPE comprising a pharmaceutical compound
US10981302B2 (en) 2013-10-17 2021-04-20 The General Hospital Corporation Peroxide cross-linking and high temperature melting
US11213397B2 (en) 2009-05-21 2022-01-04 Depuy Ireland Unlimited Company Prosthesis with surfaces having different textures and method of making the prosthesis
US11667762B2 (en) 2017-08-29 2023-06-06 The General Hospital Corporation UV-initiated reactions in polymeric materials
US11970600B2 (en) 2021-03-31 2024-04-30 The General Hospital Corporation Di-cumyl peroxide crosslinking of UHMWPE

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414049A (en) * 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
CN1123583C (en) 1994-09-21 2003-10-08 Bmg株式会社 Ultrahigh-molecular-weight polyethylene molding for artificial joint and process of producing the molding
CA2166450C (en) * 1995-01-20 2008-03-25 Ronald Salovey Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US6228900B1 (en) 1996-07-09 2001-05-08 The Orthopaedic Hospital And University Of Southern California Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6083585A (en) * 1996-09-23 2000-07-04 Bp Amoco Corporation Oxygen scavenging condensation copolymers for bottles and packaging articles
US6017975A (en) 1996-10-02 2000-01-25 Saum; Kenneth Ashley Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
IT1298376B1 (en) * 1997-12-16 2000-01-05 Samo Spa CROSS-LINKING AND STERILIZATION TREATMENT FOR THE PRODUCTION OF POLYETHYLENE PRODUCTS WITH HIGH TRIBOLOGICAL CHARACTERISTICS,
US6692679B1 (en) * 1998-06-10 2004-02-17 Depuy Orthopaedics, Inc. Cross-linked molded plastic bearings
DE69934440T2 (en) * 1998-06-10 2007-09-27 Depuy Products, Inc., Warsaw Method of producing crosslinked molded plastic bearings
WO2000032248A1 (en) * 1998-11-30 2000-06-08 The Regents Of The University Of California Plasma-assisted surface modification of polymers for medical device applications
WO2000062717A1 (en) 1999-04-21 2000-10-26 Howmedica Osteonics Corp. Selectively cross-linked polyethylene orthopedic devices
US6245276B1 (en) * 1999-06-08 2001-06-12 Depuy Orthopaedics, Inc. Method for molding a cross-linked preform
US6627141B2 (en) 1999-06-08 2003-09-30 Depuy Orthopaedics, Inc. Method for molding a cross-linked preform
US6432349B1 (en) * 1999-06-29 2002-08-13 Zimmer, Inc. Process of making an articulating bearing surface
US6143232A (en) * 1999-07-29 2000-11-07 Bristol-Meyers Squibb Company Method of manufacturing an articulating bearing surface for an orthopaedic implant
AU4890400A (en) * 1999-07-29 2001-02-01 Depuy Orthopaedics, Inc. Two step gamma irradiation of polymeric bioimplant
US6184265B1 (en) 1999-07-29 2001-02-06 Depuy Orthopaedics, Inc. Low temperature pressure stabilization of implant component
EP1404387A1 (en) * 1999-07-30 2004-04-07 New York Society For The Relief Of The Ruptured And Crippled Maintaining The Hospital For Special Surgery Fracture-resistant, cross-linked ultra high molecular weight polyethylene shaped material and articles made therefrom
US6794423B1 (en) 1999-07-30 2004-09-21 Stephen Li Fracture-resistant, cross-linked ultra high molecular weight polyethylene shaped material and articles made therefrom
US6395799B1 (en) * 2000-02-21 2002-05-28 Smith & Nephew, Inc. Electromagnetic and mechanical wave energy treatments of UHMWPE
US6414086B1 (en) * 2000-02-29 2002-07-02 Howmedica Osteonics Corp. Compositions, processes and methods of improving the wear resistance of prosthetic medical devices
US6503439B1 (en) 2000-06-15 2003-01-07 Albert H. Burstein Process for forming shaped articles of ultra high molecular weight polyethylene suitable for use as a prosthetic device or a component thereof
AU778259C (en) * 2000-07-14 2006-09-14 Depuy Orthopaedics, Inc. Method for compression molding a cross-linked preform
US6818172B2 (en) * 2000-09-29 2004-11-16 Depuy Products, Inc. Oriented, cross-linked UHMWPE molding for orthopaedic applications
AU9319201A (en) * 2000-09-29 2002-04-08 Depuy Orthopaedics Inc Supercritical fluid treatment of irradiated polyethylene
US6626947B2 (en) 2000-10-03 2003-09-30 Depuy Orthopaedics, Inc. Press fit acetabular cup and associated method for securing the cup to an acetabulum
US6664335B2 (en) 2000-11-30 2003-12-16 Cardiac Pacemakers, Inc. Polyurethane elastomer article with “shape memory” and medical devices therefrom
MXPA03004946A (en) * 2000-12-06 2005-02-14 Omlidon Technologies Llc Melt-processible, wear resistant polyethylene.
EP1700870B9 (en) 2000-12-06 2009-09-02 Eidgenössische Technische Hochschule Zürich Melt-processible, wear resistant polyethylene
DE10105085C1 (en) 2001-02-05 2002-04-18 Plus Endoprothetik Ag Rotkreuz Production of implant part, e.g. bearing for hip prosthesis, by crosslinking ultra-high molecular weight polyethylene parison with ionizing radiation includes recombination of free radicals with microwaves and/or ultrasound
JP3360073B2 (en) * 2001-02-22 2002-12-24 花王株式会社 Drink
US6821470B2 (en) * 2001-06-29 2004-11-23 Depuy Products, Inc. Joint prosthesis molding method
US6962607B2 (en) * 2001-06-30 2005-11-08 Depuy Products, Inc. Joint replacement prosthesis component with non linear insert
US7261741B2 (en) 2001-06-30 2007-08-28 Depuy Products, Inc. Prosthesis with resorbable collar
GB0122117D0 (en) * 2001-09-13 2001-10-31 United Ind Operations Ltd Method of crosslinking polyolefins
EP1308255A1 (en) * 2001-10-30 2003-05-07 Dsm N.V. Process for the manufacturing of a shaped part of ultra high molecular weight polyethylene and a fibre made with this process
US6926741B2 (en) * 2002-01-25 2005-08-09 Depuy Products, Inc. Centralizing cement plug with countersink
AU2003202796B2 (en) * 2002-01-29 2008-09-11 Plus Orthopedics Ag Sintering ultrahigh molecular weight polyethylene
EP1369094B1 (en) 2002-05-31 2014-11-26 Zimmer GmbH Implant and method of manufacturing a sterile packaged implant
US20040002770A1 (en) * 2002-06-28 2004-01-01 King Richard S. Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
US6656187B1 (en) 2002-09-03 2003-12-02 Depuy Products, Inc. Adjustable orthopaedic instrument
AU2003287190A1 (en) 2002-10-23 2004-05-13 Alastair J. T. Clemow Modular femoral component for a total knee joint replacement for minimally invasive implantation
AU2004206826B8 (en) * 2003-01-16 2009-03-26 Cambridge Polymer Group, Inc. Methods for making oxidation resistant polymeric material
US7241455B2 (en) * 2003-04-08 2007-07-10 Boston Scientific Scimed, Inc. Implantable or insertable medical devices containing radiation-crosslinked polymer for controlled delivery of a therapeutic agent
AT412969B (en) * 2003-05-19 2005-09-26 Klaus Dr Lederer NETWORKED, ULTRA-HIGH-MOLECULAR POLYETHYLENE (UHMW-PE)
US20040262809A1 (en) * 2003-06-30 2004-12-30 Smith Todd S. Crosslinked polymeric composite for orthopaedic implants
WO2005013865A2 (en) * 2003-08-07 2005-02-17 Smith & Nephew, Inc. Modified orthopaedic implants for improved sterilization
JP2005237629A (en) * 2004-02-26 2005-09-08 Kyocera Corp Artificial joint and manufacturing method of the same
US20060062825A1 (en) * 2004-04-19 2006-03-23 Maria Maccecchini Method of implanting a sterile, active agent-coated material and composition made according to same
CA2565849C (en) * 2004-05-11 2013-01-29 The General Hospital Corporation Dba Massachusetts General Hospital Methods for making oxidation resistant polymeric material
WO2006041670A2 (en) * 2004-10-08 2006-04-20 Depuy Spine, Inc. Uv device for treating osteolysis
US20060134164A1 (en) * 2004-12-17 2006-06-22 Dimauro Thomas M Th2-inducing adjuvant treatment for osteolysis
US7435372B2 (en) * 2005-03-31 2008-10-14 Zimmer, Inc. Liquid bath annealing of polymers for orthopaedic implants
US7538379B1 (en) * 2005-06-15 2009-05-26 Actel Corporation Non-volatile two-transistor programmable logic cell and array layout
ES2441608T3 (en) * 2005-08-18 2014-02-05 Zimmer Gmbh Ultra-high molecular weight polyethylene articles and methods for forming ultra-high molecular weight polyethylene articles
US8425815B2 (en) * 2005-08-22 2013-04-23 The General Hospital Corporation Highly crystalline polyethylene
US7635725B2 (en) * 2006-02-21 2009-12-22 The Brigham And Women's Hospital, Inc. Crosslinked polymers
US20080036111A1 (en) * 2006-08-09 2008-02-14 Dehchuan Sun Non-oxidizing thermally crosslinked polymeric material and medical implant
EP2460636A1 (en) * 2006-10-30 2012-06-06 Smith & Nephew Orthopaedics AG Processes comprising crosslinking polyethylene or using crosslinked polyethylene
US8562616B2 (en) 2007-10-10 2013-10-22 Biomet Manufacturing, Llc Knee joint prosthesis system and method for implantation
US8328873B2 (en) 2007-01-10 2012-12-11 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
AU2008207807B2 (en) * 2007-01-25 2013-05-16 Cambridge Polymer Group, Inc. Methods for making oxidation-resistant cross-linked polymeric materials
WO2008101134A1 (en) * 2007-02-14 2008-08-21 Brigham And Women's Hospital, Inc. Crosslinked polymers and methods of making the same
AU2008222967B2 (en) 2007-03-02 2012-12-13 Cambridge Polymer Group, Inc. Cross-linking of antioxidant-containing polymers
AU2008236996B2 (en) 2007-04-10 2012-11-08 Zimmer, Inc. An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US8664290B2 (en) 2007-04-10 2014-03-04 Zimmer, Inc. Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US20110035018A1 (en) * 2007-09-25 2011-02-10 Depuy Products, Inc. Prosthesis with composite component
US20100292374A1 (en) * 2007-10-05 2010-11-18 Anuj Bellare Crosslinked polymers and methods of making the same
WO2009048456A1 (en) * 2007-10-12 2009-04-16 Peak Plastic & Metal Products (International) Limited Wafer container with staggered wall structure
EP2249887B1 (en) 2008-01-30 2017-06-21 Zimmer, Inc. Othopedic component of low stiffness
US8268913B2 (en) * 2008-06-30 2012-09-18 Fina Technology, Inc. Polymeric blends and methods of using same
FR2936702B1 (en) * 2008-10-02 2010-12-24 Fournitures Hospitalieres Ind METHOD FOR MANUFACTURING IMPLANTS FOR HIP PROSTHESIS, AND COTYLOID IMPLANT OBTAINED THEREBY
DE102008053793A1 (en) 2008-10-21 2010-04-22 Aesculap Ag Synthetic polymer material, useful for producing medical articles e.g. catheters and trocar, comprises amino acids and/or peptides having anti-oxidative effect
CN102307945B (en) * 2008-11-20 2015-07-01 捷迈有限责任公司 Polyethylene materials
CA2706233C (en) 2009-06-04 2015-05-05 Howmedica Osteonics Corp. Orthopedic peek-on-polymer bearings
GB0922339D0 (en) 2009-12-21 2010-02-03 Mcminn Derek J W Acetabular cup prothesis and introducer thereof
DE102010029633A1 (en) 2010-06-02 2011-12-08 Hd Kunststoffe & Kunststofferzeugnisse Gmbh Comminution of ultra-high molecular weight polyethylene fibers
US8399535B2 (en) 2010-06-10 2013-03-19 Zimmer, Inc. Polymer [[s]] compositions including an antioxidant
EP2591154A2 (en) 2010-07-06 2013-05-15 Ticona GmbH High molecular weight polyethylene fibers and membranes, their production and use
KR20130124170A (en) 2010-07-06 2013-11-13 티코나 게엠베하 Process for producing high molecular weight polyethylene
WO2012006230A1 (en) 2010-07-06 2012-01-12 Ticona Gmbh Process for producing high molecular weight polyethylene
BR112012032879A2 (en) 2010-07-06 2016-11-08 Ticona Gmbh high molecular weight polyethylene molded articles, their production and use
US9212234B2 (en) 2010-07-06 2015-12-15 Ticona Gmbh Process for producing high molecular weight polyethylene
US8747479B2 (en) 2011-04-26 2014-06-10 Michael A. McShane Tibial component
WO2014075727A1 (en) * 2012-11-15 2014-05-22 Abb Research Ltd Cross-linked polyethylene used for electrical insulation applications
US9708467B2 (en) 2013-10-01 2017-07-18 Zimmer, Inc. Polymer compositions comprising one or more protected antioxidants
EP3116941A1 (en) 2014-03-12 2017-01-18 Zimmer, Inc. Melt-stabilized ultra high molecular weight polyethylene and method of making the same
CA2969751C (en) 2014-12-03 2020-09-22 Zimmer, Inc. Antioxidant-infused ultra high molecular weight polyethylene
KR102400422B1 (en) * 2017-11-14 2022-05-19 가부시키가이샤 도요다 지도숏키 Sliding member and manufacturing method thereof
CN111436938B (en) * 2020-04-30 2023-11-14 厦门中翎易优创科技有限公司 Limb swelling monitoring device and method
CN113980324A (en) * 2021-11-02 2022-01-28 苏州微创关节医疗科技有限公司 Ultra-high molecular weight polyethylene implant, preparation method thereof and artificial joint

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5435723A (en) * 1993-08-18 1995-07-25 O'brien; Gary R. Endosseous dental implant system
WO1998001085A1 (en) 1996-07-09 1998-01-15 The Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6165220A (en) * 1996-10-15 2000-12-26 The Orthopaedic Hospital Wear resistant surface-gradient crosslinked polyethylene

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297641A (en) 1964-01-17 1967-01-10 Grace W R & Co Process for cross-linking polyethylene
DE1241994B (en) 1964-01-31 1967-06-08 Glanzstoff Ag Process for the saturation of double bonds in polyolefins
BE794718Q (en) 1968-12-20 1973-05-16 Dow Corning Ltd OLEFINS CROSS-LINKING PROCESS
JPS4810618B1 (en) 1969-03-10 1973-04-05
US3758273A (en) 1970-04-03 1973-09-11 Gillette Co Processes for sterilizing polypropylene objects
US3944536A (en) 1973-06-18 1976-03-16 E. I. Du Pont De Nemours & Company Exceptionally rigid and tough ultrahigh molecular weight linear polyethylene
US4138382A (en) 1978-05-01 1979-02-06 Dow Corning Corporation Hydrophilic, water-swellable, crosslinked, copolymer gel and prosthesis employing same
DE3131812C2 (en) 1981-08-12 1983-06-16 Hewing GmbH & Co, 4434 Ochtrup Process for the production of moldings from polyolefin molding compositions crosslinked by irradiation with electron beams
JPS5829841A (en) 1981-08-14 1983-02-22 Asahi Chem Ind Co Ltd Improve polyethylene composition
JPS58157830A (en) 1982-03-12 1983-09-20 Nitto Electric Ind Co Ltd Preparation of sliding sheet
US4483333A (en) 1982-06-01 1984-11-20 Wrf/Aquaplast Corporation Orthopedic cast
US4816517A (en) 1982-09-29 1989-03-28 Vulkor, Incorporated Crosslinked polymer interdispersions containing polyolefin and method of making
JPS59168050A (en) 1983-03-14 1984-09-21 Mitsuboshi Belting Ltd Ultra-high-molecular-weight polyethylene composition having improved resistance to friction and wear
US4518552A (en) 1983-11-09 1985-05-21 Mitsuboshi Belting Ltd. Method of producing accurately sized material of ultra high molecular weight polyethylene
GB8332952D0 (en) 1983-12-09 1984-01-18 Ward I M Polymer irradiation
US4539374A (en) 1984-03-21 1985-09-03 E. I. Du Pont De Nemours And Company Polyolefin with improved processing properties
DE169259T1 (en) * 1984-07-25 1986-04-30 Surgical Patent Products Inc. Ltd., Panama VESSEL PROSTHESES FOR DRY STORAGE, METHOD FOR TREATMENT AND THEIR USE IN SURGERY.
US5160472A (en) 1984-10-24 1992-11-03 Zachariades Anagnostis E Method of producing composite structures of ultra-high-molecular-weight polymers, such as ultra-high-molecular-weight polyethylene products
US4944974A (en) 1984-10-24 1990-07-31 Zachariades Anagnostis E Composite structures of ultra-high-molecular-weight polymers, such as ultra-high-molecular-weight polyethylene products, and method of producing such structures
US4655769A (en) 1984-10-24 1987-04-07 Zachariades Anagnostis E Ultra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states
JPS61204372A (en) 1985-03-06 1986-09-10 Univ Osaka Method for making material amorphous by use of implantation of heterogeneous atom into solid by electron beam
FR2578780B1 (en) 1985-03-12 1987-08-14 Commissariat Energie Atomique HIGH MOLECULAR WEIGHT POLYOLEFIN PART, PARTICULARLY FOR JOINT PROSTHESIS, AND ITS MANUFACTURING METHOD BY CLOSED MATRIX FORGING
US4876049A (en) 1985-11-21 1989-10-24 Nippon Petrochemicals Co., Ltd. Method for preparing molded articles of ultra-high molecular weight polyethylene
CA1279167C (en) 1985-11-30 1991-01-22 Mitsui Chemicals, Incorporated Molecularly oriented, silane-crosslinked ultra-high- molecular-weight polyethylene molded article and process for preparation thereof
JPH0639499B2 (en) 1986-04-17 1994-05-25 日本石油株式会社 Method for producing crosslinked ultra high molecular weight polyethylene
US4743493A (en) 1986-10-06 1988-05-10 Spire Corporation Ion implantation of plastics
US4888369A (en) 1987-01-21 1989-12-19 Himont Incorporated Polypropylene composition resistant to high energy radiation, and radiation sterilized articles therefrom
BE1001574A6 (en) 1988-04-07 1989-12-05 Flatech Internationa B V B A Orthopaedic and podological material - comprising thermoplastic high density polyethylene contg. silane(s)
FR2631832B1 (en) 1988-05-24 1994-05-27 Unirec METHOD FOR REDUCING THE COEFFICIENT OF FRICTION AND WEAR BETWEEN A METAL PIECE AND A PIECE BASED ON AN ORGANIC POLYMER OR COPOLYMER AND ITS APPLICATION TO JOINT PROSTHESES
WO1990006139A1 (en) * 1988-12-02 1990-06-14 E.I. Du Pont De Nemours And Company Ultrahigh molecular weight linear polyethylene, articles and processes of manufacture
US5478906A (en) 1988-12-02 1995-12-26 E. I. Du Pont De Nemours And Company Ultrahigh molecular weight linear polyethylene and articles thereof
CA2021814C (en) 1989-07-25 2002-04-02 James A. Davidson Zirconium alloy-based prosthesis with zirconium oxide or zirconium nitride coating
US5024670A (en) 1989-10-02 1991-06-18 Depuy, Division Of Boehringer Mannheim Corporation Polymeric bearing component
US5037928A (en) 1989-10-24 1991-08-06 E. I. Du Pont De Nemours And Company Process of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
US5130376A (en) 1990-04-23 1992-07-14 Hercules Incorporated UHMWPE/styrenic molding compositions with improved flow properties and impact strength
US5236563A (en) 1990-06-18 1993-08-17 Advanced Surface Technology Inc. Surface-modified bioabsorbables
US5133757A (en) 1990-07-31 1992-07-28 Spire Corporation Ion implantation of plastic orthopaedic implants
US5210130A (en) 1990-08-07 1993-05-11 E. I. Du Pont De Nemours And Company Homogeneous, high modulus ultrahigh molecular weight polyethylene composites and processes for the preparation thereof
US5702448A (en) 1990-09-17 1997-12-30 Buechel; Frederick F. Prosthesis with biologically inert wear resistant surface
DE4030564A1 (en) 1990-09-27 1992-04-02 Hoechst Ag GRAFT POLYMER BASED ON ULTRA HIGH MOLECULAR POLYETHYLENE
US5192323A (en) 1990-11-05 1993-03-09 Zimmer, Inc. Method of surface hardening orthopedic implant devices
JPH04185651A (en) 1990-11-21 1992-07-02 Fujikura Ltd Production of crosslinked polyolefin molding
JPH04198242A (en) 1990-11-27 1992-07-17 Komatsu Ltd Ultrahigh-molecular-weight polyethylene composition
US5508319A (en) 1991-06-21 1996-04-16 Montell North America Inc. High melt strength, ethylene polymer, process for making it, and use thereof
CA2124356A1 (en) * 1991-11-27 1993-06-10 Edward George Howard, Jr. Ultrahigh molecular weight linear polyethylene, articles and processes of manufacture
US5505984A (en) 1993-01-21 1996-04-09 England; Garry L. Method for forming biocompatible components using an isostatic press
US5443519A (en) 1993-04-22 1995-08-22 Implex Corporation Prosthetic ellipsoidal acetabular cup
US5414049A (en) * 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
US5549700A (en) 1993-09-07 1996-08-27 Ortho Development Corporation Segmented prosthetic articulation
US5407623A (en) 1994-01-06 1995-04-18 Polteco, Inc. Process for obtaining ultra-high modulus line products with enhanced mechanical properties
AU1542895A (en) 1994-02-03 1995-08-21 Smith & Nephew Plc Surface treatment
US5593719A (en) 1994-03-29 1997-01-14 Southwest Research Institute Treatments to reduce frictional wear between components made of ultra-high molecular weight polyethylene and metal alloys
US5709020A (en) 1994-07-19 1998-01-20 University Of Kentucky Research Foundation Method for reducing the generation of wear particulates from an implant
US5515590A (en) 1994-07-19 1996-05-14 University Of Kentucky Research Foundation Method for reducing the generation of wear particulates from an implant
CN1123583C (en) * 1994-09-21 2003-10-08 Bmg株式会社 Ultrahigh-molecular-weight polyethylene molding for artificial joint and process of producing the molding
US5507804A (en) 1994-11-16 1996-04-16 Alcon Laboratories, Inc. Cross-linked polyethylene oxide coatings to improve the biocompatibility of implantable medical devices
US5609638A (en) 1994-11-29 1997-03-11 Zimmer, Inc. Reinforced polyethylene for articular surfaces
ES2340999T3 (en) 1994-11-30 2010-06-14 Biomet 3I, Llc PREPARATION OF THE SURFACE OF AN IMPLANT.
CA2166450C (en) * 1995-01-20 2008-03-25 Ronald Salovey Chemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US5577368A (en) 1995-04-03 1996-11-26 Johnson & Johnson Professional, Inc. Method for improving wear resistance of polymeric bioimplantable components
JP2984203B2 (en) * 1995-10-31 1999-11-29 京セラ株式会社 Manufacturing method of sliding member for artificial joint
US5674293A (en) 1996-01-19 1997-10-07 Implant Sciences Corp. Coated orthopaedic implant components
WO1997029793A1 (en) * 1996-02-13 1997-08-21 Massachusetts Institute Of Technology Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US5879400A (en) 1996-02-13 1999-03-09 Massachusetts Institute Of Technology Melt-irradiated ultra high molecular weight polyethylene prosthetic devices
US6017975A (en) 1996-10-02 2000-01-25 Saum; Kenneth Ashley Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US5879407A (en) 1997-07-17 1999-03-09 Waggener; Herbert A. Wear resistant ball and socket joint
US6318158B1 (en) * 2000-03-01 2001-11-20 Coulter International Corp. Sample preparation and delivery system employing external sonicator

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5435723A (en) * 1993-08-18 1995-07-25 O'brien; Gary R. Endosseous dental implant system
WO1998001085A1 (en) 1996-07-09 1998-01-15 The Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US6165220A (en) * 1996-10-15 2000-12-26 The Orthopaedic Hospital Wear resistant surface-gradient crosslinked polyethylene

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"Irradiation Effects on Polymers", edited by D.W. Clegg and A.A. Collyer, Elsevier Applied Sc(1991).
"Radiation Effects on Polymers", edited by R. L. Clough and S. W. Shalaby, ACS Symposium(1991).
A. Wang, C. Stark, J.H. Dumbleton, "Role of cyclic plastic deformation in the wear of UHMWPE acetabular cups", Journal of Biomedical Materials Research, vol. 29, pp. 619-626, (1995).
A. Wang, D.C. Sun, C. Stark, J.H. Dumbleton, Wear, p. 181-183:241-249 (1995).
A.F. Booth, "Industrial Sterilisation Technologies: New and Old trends Shape Manufacturer Choices", Medical Device & Diagnostic Industry, pp. 64-72, Feb. (1995).
B. Hinsch, "Sterilisation Methods for Implants Made of UHMWPE", inUltra-High Molecular Weight Polyethylene as Biomaterials in Orthopedic Surgery, Toronto: Hogrefe & Huber Publishers, pp. 63-65, (1991).
D.C. Sun, Stark., J. H. Dumbleton, "Development of an Accelerated Aging Method For Evaluation of Longterm Irradiation Effects on UHMWPE Implants", Polymer Preprints, vol. 35, No. 2, pp. 969-970, (1994).
P. Eyerer, M. Kurth, H. A. McKellop and T. Mittimeier, "Characterization of UHMWPE hip cups run stimulators", J. Biomedical Materials Research, vol. 21, pp. 275-291, (1987).

Cited By (180)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8865788B2 (en) 1996-02-13 2014-10-21 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US6464926B1 (en) 1996-02-13 2002-10-15 The General Hospital Corporation Process of making ultra high molecular weight polyethylene prosthetic devices
US6786933B2 (en) 1996-02-13 2004-09-07 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US7858671B2 (en) 1996-02-13 2010-12-28 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20030105182A1 (en) * 1996-02-13 2003-06-05 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US8563623B2 (en) 1996-02-13 2013-10-22 The General Hospital Corporation Radiation melt treated ultra high molecular weight polyethylene prosthetic devices
US20050010288A1 (en) * 1996-02-13 2005-01-13 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20020156536A1 (en) * 1996-02-13 2002-10-24 Harris William H. Polyethylene hip joint prosthesis with extended range of motion
US8263676B2 (en) 1996-02-13 2012-09-11 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US6641617B1 (en) 1996-02-13 2003-11-04 The General Hospital Corp. Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method
US20050267594A1 (en) * 1996-02-13 2005-12-01 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20050096749A1 (en) * 1996-02-13 2005-05-05 The General Hospital Corporation Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US20050056971A1 (en) * 1996-02-13 2005-03-17 Merrill Edward W. Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US6800670B2 (en) 1996-07-09 2004-10-05 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US8008365B2 (en) * 1996-07-09 2011-08-30 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US8003709B2 (en) * 1996-07-09 2011-08-23 Orthopaedic Hospital Crosslinking of polyethylene for low wear using radiation and thermal treatments
US9302028B2 (en) 2000-04-27 2016-04-05 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US8658710B2 (en) 2000-04-27 2014-02-25 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US8796347B2 (en) 2000-04-27 2014-08-05 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US9155817B2 (en) 2000-04-27 2015-10-13 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US20070293647A1 (en) * 2000-04-27 2007-12-20 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US20030212161A1 (en) * 2000-04-27 2003-11-13 Mckellop Harry A Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US9242025B2 (en) 2000-04-27 2016-01-26 Orthopaedic Hospital Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them
US8608806B2 (en) 2000-07-31 2013-12-17 The General Hospital Corporation Monopolar constrained acetabular component
US9060865B2 (en) 2000-07-31 2015-06-23 The General Hospital Corporation Monopolar constrained acetabular component
US7169186B2 (en) 2000-07-31 2007-01-30 Massachusetts General Hospital Monopolar constrained acetabular component
US20030050703A1 (en) * 2000-07-31 2003-03-13 Harris William H. Acetabular components that decrease risks of dislocation
US20070135927A1 (en) * 2000-07-31 2007-06-14 Massachusetts General Hospital acetabular components that decrease risks of dislocation
US10188521B2 (en) 2000-11-28 2019-01-29 Medidea, Llc Multiple-cam, posterior-stabilized knee prosthesis
US9492280B2 (en) 2000-11-28 2016-11-15 Medidea, Llc Multiple-cam, posterior-stabilized knee prosthesis
EP2272542A2 (en) 2001-02-23 2011-01-12 Smith and Nephew, Inc. Cross-linked ultra-high molecular weight polyethylene for use as medical implant
US20040111160A1 (en) * 2001-07-18 2004-06-10 Evans David L. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US6652586B2 (en) * 2001-07-18 2003-11-25 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US7182784B2 (en) 2001-07-18 2007-02-27 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US20080318022A1 (en) * 2001-10-30 2008-12-25 Colorado State University Research Foundation (Csurf), Colorado Non-Profit Outer layer material having entanglement of hydrophobic polymer host blended with a maleated hydrophobic polymer co-host, and hydrophilic polymer guest
US20030083433A1 (en) * 2001-10-30 2003-05-01 James Susan P. Outer layer having entanglement of hydrophobic polymer host and hydrophilic polymer guest
US9533077B2 (en) 2001-10-30 2017-01-03 Colorado State University Research Foundation Outer layer having entanglement of hydrophobic polymer host blended with a maleated hydrophobic polymer co-host, and hydrophilic polymer guest
US9567447B2 (en) 2001-10-30 2017-02-14 Colorado State University Research Foundation Outer layer having entanglement of hydrophobic polymer host and hydrophilic polymer guest
US10435523B2 (en) 2001-10-30 2019-10-08 Colorado State University Research Foundation Material comprising outer layer having entanglement of hydrophobic polymer host blended with anhydride functionalized hydrophobic polymer co-host and hydrophilic guest
US20100150983A1 (en) * 2001-10-30 2010-06-17 Colorado State University Research Foundation Outer layer having entanglement of hydrophobic polymer host and hydrophilic polymer guest
US8524884B2 (en) 2001-10-30 2013-09-03 Colorado State University Research Foundation Outer layer material having entanglement of hydrophobic polymer hostblended with a maleated hydrophobic polymer co-host, and hydrophilic polymer guest
US7662954B2 (en) 2001-10-30 2010-02-16 Colorado State University Research Foundation Outer layer having entanglement of hydrophobic polymer host and hydrophilic polymer guest
US8524886B2 (en) 2001-10-30 2013-09-03 Colorado State University Research Foundation Outer layer having entanglement of hydrophobic polymer host and hydrophilic polymer guest
US20030125513A1 (en) * 2001-12-12 2003-07-03 Richard King Orthopaedic device for implantation in the body of an animal and method for making the same
US20070093909A1 (en) * 2001-12-12 2007-04-26 Richard King Orthopaedic device for implantation in the body of an animal and method for making the same
US7160492B2 (en) 2001-12-12 2007-01-09 Depuy Products, Inc. Orthopaedic device for implantation in the body of an animal and method for making the same
WO2003049930A1 (en) * 2001-12-12 2003-06-19 Depuy Products, Inc. Orthopaedic device and method for making same
US6852772B2 (en) 2002-01-04 2005-02-08 Massachusetts Gerneral Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US8076387B2 (en) 2002-01-04 2011-12-13 The General Hospital Corporation High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20080090933A1 (en) * 2002-01-04 2008-04-17 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20070004818A1 (en) * 2002-01-04 2007-01-04 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20030149125A1 (en) * 2002-01-04 2003-08-07 Muratoglu Orhun K. High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US7304097B2 (en) 2002-01-04 2007-12-04 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US7507774B2 (en) 2002-01-04 2009-03-24 The General Hospital Corporation High modules crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20050124718A1 (en) * 2002-01-04 2005-06-09 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US7569620B2 (en) 2002-01-04 2009-08-04 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US7166650B2 (en) 2002-01-04 2007-01-23 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20090326659A1 (en) * 2002-01-04 2009-12-31 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20100262251A1 (en) * 2002-01-04 2010-10-14 The General Hospital Corporation High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
US20080039545A1 (en) * 2002-01-04 2008-02-14 Massachusetts General Hospital High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
AU2009201352B2 (en) * 2002-01-28 2011-09-15 Depuy Products, Inc. Composite prosthetic bearing having a crosslinked articulating surface and method for making the same
US20070118227A1 (en) * 2002-01-28 2007-05-24 Richard King Composite prosthetic bearing constructed of polyethylene and an ethylene-acrylate copolymer
US20110039014A1 (en) * 2002-01-28 2011-02-17 Richard King Composite prosthetic bearing having a crosslinked articulating surface and method for making the same
US7186364B2 (en) 2002-01-28 2007-03-06 Depuy Products, Inc. Composite prosthetic bearing constructed of polyethylene and an ethylene-acrylate copolymer and method for making the same
EP1332735A1 (en) 2002-01-28 2003-08-06 Depuy Products, Inc. Composite prosthetic bearing having a crosslinked articulating surface and method of manufacture
US7819925B2 (en) 2002-01-28 2010-10-26 Depuy Products, Inc. Composite prosthetic bearing having a crosslinked articulating surface and method for making the same
US9650476B2 (en) 2002-06-06 2017-05-16 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US9181409B2 (en) 2002-06-06 2015-11-10 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
US20040210316A1 (en) * 2003-04-15 2004-10-21 Richard King Implantable orthopaedic device and method for making the same
US7938861B2 (en) 2003-04-15 2011-05-10 Depuy Products, Inc. Implantable orthopaedic device and method for making the same
US7214764B2 (en) 2003-06-30 2007-05-08 Depuy Products, Inc. Free radical quench process for irradiated ultrahigh molecular weight polyethylene
US20040265165A1 (en) * 2003-06-30 2004-12-30 Depuy Products, Inc. Free radical quench process for irradiated ultrahigh molecular weight polyethylene
US20040266903A1 (en) * 2003-06-30 2004-12-30 Depuy Products, Inc. Free radical quench process for irradiated ultrahigh molecular weight polyethylene
US20100283184A1 (en) * 2003-09-19 2010-11-11 Depuy Products, Inc. Process for producing medical implant or medical implant part comprising porous uhmwpe
US7923512B2 (en) 2003-09-19 2011-04-12 Depuy Products, Inc. Process for producing medical implant or medical implant part comprising porous UHMWPE
US7781526B2 (en) 2003-09-19 2010-08-24 Depuy Products, Inc. Medical implant or medical implant part comprising porous UHMWPE and process for producing the same
US20080044676A1 (en) * 2003-09-30 2008-02-21 Depuy Products, Inc. Method for producing medical implant or medical implant part
EP1520877A1 (en) 2003-09-30 2005-04-06 Depuy Products, Inc. Medical implant or medical implant part with ultrahigh molecular weight polyethylene and at least one hydrophilic polymer
US7785508B2 (en) 2003-09-30 2010-08-31 Depuy Products, Inc. Method for producing medical implant or medical implant part
EP1720485A4 (en) * 2004-02-03 2012-01-25 Gen Hospital Corp Highly crystalline cross-linked oxidation-resistant polyethylene
EP1720485A2 (en) * 2004-02-03 2006-11-15 The Massachusetts General Hospital Highly crystalline cross-linked oxidation-resistant polyethylene
AU2005202521B2 (en) * 2004-06-30 2011-03-03 Depuy Products, Inc. Low crystalline polymeric material for orthopaedic implants and an associated method
EP1618902A1 (en) * 2004-06-30 2006-01-25 DePuy Products Low crystalline polymeric material for orthopaedic implants
US8137608B2 (en) 2004-10-07 2012-03-20 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US8262976B2 (en) 2004-10-07 2012-09-11 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7780896B2 (en) 2004-10-07 2010-08-24 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US8398913B2 (en) 2004-10-07 2013-03-19 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7993401B2 (en) 2004-10-07 2011-08-09 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7462318B2 (en) 2004-10-07 2008-12-09 Biomet Manufacturing Corp. Crosslinked polymeric material with enhanced strength and process for manufacturing
US7927536B2 (en) 2004-10-07 2011-04-19 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US9017590B2 (en) 2004-10-07 2015-04-28 Biomet Manufacturing, Llc Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7344672B2 (en) 2004-10-07 2008-03-18 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7547405B2 (en) 2004-10-07 2009-06-16 Biomet Manufacturing Corp. Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7335697B2 (en) 2004-12-23 2008-02-26 Depuy Products, Inc. Polymer composition comprising cross-linked polyethylene and methods for making the same
EP2113530A1 (en) 2004-12-23 2009-11-04 DePuy Products, Inc. Polymer composition comprising cross-linked polyethylene
US20060142449A1 (en) * 2004-12-23 2006-06-29 Depuy Products, Inc. Polymer composition comprising cross-linked polyethylene and methods for making the same
EP1676875A1 (en) 2004-12-23 2006-07-05 DePuy Products, Inc. Polymer composition comprising cross-linked polyethylene and methods for making the same
US7883653B2 (en) 2004-12-30 2011-02-08 Depuy Products, Inc. Method of making an implantable orthopaedic bearing
US7879275B2 (en) 2004-12-30 2011-02-01 Depuy Products, Inc. Orthopaedic bearing and method for making the same
US7896921B2 (en) 2004-12-30 2011-03-01 Depuy Products, Inc. Orthopaedic bearing and method for making the same
US7803310B2 (en) 2005-06-14 2010-09-28 Omni Life Science, Inc. Crosslinked polyethylene article
US20080197541A1 (en) * 2005-06-14 2008-08-21 Omni Life Science, Inc Crosslinked Polyethylene Article
US8343230B2 (en) 2005-09-22 2013-01-01 Depuy Products, Inc. Orthopaedic bearing material
US20070067044A1 (en) * 2005-09-22 2007-03-22 Depuy Products, Inc. Orthopaedic bearing material
US20070077268A1 (en) * 2005-09-30 2007-04-05 Depuy Products, Inc. Hydrophobic carrier modified implants for beneficial agent delivery
CZ297700B6 (en) * 2005-12-13 2007-03-07 Ústav makromolekulární chemie AV CR Modification method of ultra high-molecular polyethylene for manufacture of joint prostheses with increased service life
US20070232761A1 (en) * 2006-03-31 2007-10-04 Depuy Products, Inc. Bearing material of medical implant having reduced wear rate and method for reducing wear rate
US7812098B2 (en) 2006-03-31 2010-10-12 Depuy Products, Inc. Bearing material of medical implant having reduced wear rate and method for reducing wear rate
US20100137522A1 (en) * 2006-08-25 2010-06-03 Depuy Products, Inc. Bearing material of medical implant and methods for making it
US7683133B2 (en) 2006-08-25 2010-03-23 Depuy Products, Inc. Bearing material of medical implant and methods for making it
US8641959B2 (en) 2007-07-27 2014-02-04 Biomet Manufacturing, Llc Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US9421104B2 (en) 2007-07-27 2016-08-23 Biomet Manufacturing, Llc Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US9398956B2 (en) 2007-09-25 2016-07-26 Depuy (Ireland) Fixed-bearing knee prosthesis having interchangeable components
US20110035017A1 (en) * 2007-09-25 2011-02-10 Depuy Products, Inc. Prosthesis with cut-off pegs and surgical method
US9278003B2 (en) 2007-09-25 2016-03-08 Depuy (Ireland) Prosthesis for cementless fixation
US8632600B2 (en) 2007-09-25 2014-01-21 Depuy (Ireland) Prosthesis with modular extensions
US9204967B2 (en) 2007-09-28 2015-12-08 Depuy (Ireland) Fixed-bearing knee prosthesis having interchangeable components
US8128703B2 (en) 2007-09-28 2012-03-06 Depuy Products, Inc. Fixed-bearing knee prosthesis having interchangeable components
US9326864B2 (en) 2008-06-30 2016-05-03 Depuy (Ireland) Orthopaedic knee prosthesis having controlled condylar curvature
US11730602B2 (en) 2008-06-30 2023-08-22 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US12109119B2 (en) 2008-06-30 2024-10-08 Depuy Ireland Unlimited Company Orthopaedic femoral component having controlled condylar curvature
US8734522B2 (en) 2008-06-30 2014-05-27 Depuy (Ireland) Posterior stabilized orthopaedic prosthesis
US12059356B2 (en) 2008-06-30 2024-08-13 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US8236061B2 (en) 2008-06-30 2012-08-07 Depuy Products, Inc. Orthopaedic knee prosthesis having controlled condylar curvature
US8795380B2 (en) 2008-06-30 2014-08-05 Depuy (Ireland) Orthopaedic knee prosthesis having controlled condylar curvature
US8828086B2 (en) 2008-06-30 2014-09-09 Depuy (Ireland) Orthopaedic femoral component having controlled condylar curvature
US8834575B2 (en) 2008-06-30 2014-09-16 Depuy (Ireland) Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US9452053B2 (en) 2008-06-30 2016-09-27 Depuy (Ireland) Orthopaedic knee prosthesis having controlled condylar curvature
US8206451B2 (en) 2008-06-30 2012-06-26 Depuy Products, Inc. Posterior stabilized orthopaedic prosthesis
US11369478B2 (en) 2008-06-30 2022-06-28 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US8192498B2 (en) 2008-06-30 2012-06-05 Depuy Products, Inc. Posterior cructiate-retaining orthopaedic knee prosthesis having controlled condylar curvature
US8187335B2 (en) 2008-06-30 2012-05-29 Depuy Products, Inc. Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US11337823B2 (en) 2008-06-30 2022-05-24 Depuy Ireland Unlimited Company Orthopaedic femoral component having controlled condylar curvature
US9119723B2 (en) 2008-06-30 2015-09-01 Depuy (Ireland) Posterior stabilized orthopaedic prosthesis assembly
US10849760B2 (en) 2008-06-30 2020-12-01 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US10729551B2 (en) 2008-06-30 2020-08-04 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US10543098B2 (en) 2008-06-30 2020-01-28 Depuy Ireland Unlimited Company Orthopaedic femoral component having controlled condylar curvature
US9168145B2 (en) 2008-06-30 2015-10-27 Depuy (Ireland) Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US10265180B2 (en) 2008-06-30 2019-04-23 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US10179051B2 (en) 2008-06-30 2019-01-15 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US9204968B2 (en) 2008-06-30 2015-12-08 Depuy (Ireland) Posterior stabilized orthopaedic prosthesis
US9220601B2 (en) 2008-06-30 2015-12-29 Depuy (Ireland) Orthopaedic femoral component having controlled condylar curvature
US9937049B2 (en) 2008-06-30 2018-04-10 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US9931216B2 (en) 2008-06-30 2018-04-03 Depuy Ireland Unlimited Company Orthopaedic femoral component having controlled condylar curvature
US9539099B2 (en) 2008-06-30 2017-01-10 Depuy Ireland Unlimited Company Orthopaedic knee prosthesis having controlled condylar curvature
US8784496B2 (en) 2008-06-30 2014-07-22 Depuy (Ireland) Orthopaedic knee prosthesis having controlled condylar curvature
US20100036491A1 (en) * 2008-08-05 2010-02-11 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US8303657B2 (en) 2008-08-05 2012-11-06 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US8439975B2 (en) 2008-08-05 2013-05-14 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US8133436B2 (en) 2008-08-05 2012-03-13 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US8241564B1 (en) 2008-08-05 2012-08-14 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US20110224325A1 (en) * 2008-08-05 2011-09-15 Howmedica Osteonics Corp. Polyethylene cross-linked with an anthocyanin
US11850329B2 (en) 2009-02-20 2023-12-26 The General Hospital Corporation Methods of making a layered consolidated UHMWPE for use as a medical implant, and products made by the methods
US10967100B2 (en) 2009-02-20 2021-04-06 The General Hospital Corporation Methods of making a layered consolidated UHMWPE comprising a pharmaceutical compound
US11213397B2 (en) 2009-05-21 2022-01-04 Depuy Ireland Unlimited Company Prosthesis with surfaces having different textures and method of making the prosthesis
US10433964B2 (en) 2009-05-21 2019-10-08 Depuy Ireland Unlimited Company Prosthesis with surfaces having different textures and method of making the prosthesis
EP2316382A1 (en) 2009-10-30 2011-05-04 DePuy Products, Inc. Prosthesis for cementless fixation
EP2319460A1 (en) 2009-10-30 2011-05-11 DePuy Products, Inc. Prosthesis with cut-off pegs
EP2617392A1 (en) 2009-10-30 2013-07-24 DePuy Products, Inc. Prosthesis with surfaces having different textures
EP2319462A1 (en) 2009-10-30 2011-05-11 DePuy Products, Inc. Prosthesis with composite component
EP2730253A1 (en) 2009-10-30 2014-05-14 DePuy Synthes Products, LLC Prosthesis with surfaces having different textures
EP2606857A1 (en) 2009-10-30 2013-06-26 DePuy Products, Inc. Prosthesis with composite component
EP2316383A1 (en) 2009-10-30 2011-05-04 DePuy Products, Inc. Prosthesis with surfaces having different textures
US8715359B2 (en) 2009-10-30 2014-05-06 Depuy (Ireland) Prosthesis for cemented fixation and method for making the prosthesis
EP2316384A1 (en) 2009-10-30 2011-05-04 DePuy Products, Inc. Prosthesis with modular extensions
US9011547B2 (en) 2010-01-21 2015-04-21 Depuy (Ireland) Knee prosthesis system
EP2384774A2 (en) 2010-05-07 2011-11-09 Howmedica Osteonics Corp. Surface crosslinked polyethylene
WO2012051397A1 (en) 2010-10-14 2012-04-19 Depuy Products, Inc. Prosthesis with surfaces having different textures and method of making the prosthesis
EP2777624A1 (en) 2013-03-15 2014-09-17 DePuy Synthes Products, LLC Orthopaedic prosthesis
US9237953B2 (en) 2013-03-15 2016-01-19 Depuy (Ireland) Mechanical assembly of pegs to prosthesis
US9586370B2 (en) 2013-08-15 2017-03-07 Biomet Manufacturing, Llc Method for making ultra high molecular weight polyethylene
US10981302B2 (en) 2013-10-17 2021-04-20 The General Hospital Corporation Peroxide cross-linking and high temperature melting
WO2015095009A1 (en) 2013-12-17 2015-06-25 Depuy (Ireland) Low profile mobile/fixed prosthetic knee systems
US9144499B2 (en) 2013-12-17 2015-09-29 Depuy (Ireland) Low profile mobile/fixed prosthetic knee systems
EP2921186A1 (en) 2014-03-21 2015-09-23 Howmedica Osteonics Corp. Annealing method for cross-linked polyethylene
EP3300698A1 (en) 2016-09-28 2018-04-04 DePuy Synthes Products, Inc. Method of texturing prosthetic implants
US10070959B2 (en) 2016-09-28 2018-09-11 DePuy Synthes Products, Inc. Method of texturing prosthetic implants
US11667762B2 (en) 2017-08-29 2023-06-06 The General Hospital Corporation UV-initiated reactions in polymeric materials
CN111653718A (en) * 2020-07-24 2020-09-11 天津市捷威动力工业有限公司 Polyethylene diaphragm for high-energy-density lithium ion battery, preparation method and application
US11970600B2 (en) 2021-03-31 2024-04-30 The General Hospital Corporation Di-cumyl peroxide crosslinking of UHMWPE

Also Published As

Publication number Publication date
DE69737356D1 (en) 2007-03-29
US6562540B2 (en) 2003-05-13
DE69737356T2 (en) 2007-08-16
US6017975A (en) 2000-01-25
US6242507B1 (en) 2001-06-05
EP0935474A1 (en) 1999-08-18
WO1998014223A1 (en) 1998-04-09
JP5014528B2 (en) 2012-08-29
JP2009261978A (en) 2009-11-12
US20020107300A1 (en) 2002-08-08
JP2001523982A (en) 2001-11-27
EP0935474B1 (en) 2007-02-14
AU4742697A (en) 1998-04-24

Similar Documents

Publication Publication Date Title
US6316158B1 (en) Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US7166650B2 (en) High modulus crosslinked polyethylene with reduced residual free radical concentration prepared below the melt
JP5763115B2 (en) Oxidation resistant homogenized polymeric material
EP1493775B1 (en) Free radical quench process for irradiated ultrahigh molecular weight
AU742681B2 (en) Wear resistant surface-gradient cross-linked polyethylene
US20070265369A1 (en) Highly Crystalline Cross-Linked Oxidation-Resistant Polyethylene
CA2619869A1 (en) Highly cross-linked and wear-resistant polyethylene prepared below the melt
US20040265165A1 (en) Free radical quench process for irradiated ultrahigh molecular weight polyethylene

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12